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SUT4MARY
Smooth muscles as a group exihit great diversity of 
pharmacological and physiological properties. This makes it 
impossible to produce any but extremely generalised schemes for 
smooth muscle contractile mechanisms. However, knowledge of the 
detailed physiology and pharmacology of specific types of smooth 
muscle has been growing at an increasing rate, especially regarding 
vascular and visceral muscles. The rat anococcygeus muscle has, 
however, been investigated little. This work describes the 
excitation- contraction coupling mechanism in this preparation.
The rat anococcygeus muscle was found to contract to all three 
of the agonists used ( noradrenaline, acetylcholine and potassium 
chloride ). In the first section of this work the properties of 
these contractions were investigated. It was found that the 
contractions induced by each agonist exibited different 
pharmacological properties, ( with regard to low calcium, sodium 
nitroprusside, verapamil, Stellazine and theophylline ). This can 
be taken as an indication that the different agonists use different 
activation pathways.
Electrophysiological studies showed that the membrane 
potential per se is not important in the regulation of contraction.
( ie. the depolarisation produced by an agonist is not simply 
related to the tension produced ). KCl produces the greatest 
change in membrane potential ( from -55mV to -2QmV for a maximal 
dose ), but produces * the least rise in tension of the three 
agonists.
Evidence from other preparations and the results of the 
experiments with Stellasine suggest that the rise in tension 
produced by the agonists is not simply related to the rise in 
intracellular calcium concentration, but that some amplification of 
the response ocurrs.
The way in which the agonists produce this amplification of 
the response is suggested as being related to changes in the levels 
of the cyclic nucleotides, cAMP and cGMP within the cells. It was 
found that the agonists did not substantially affect cAMP levels, 
but that all three reduced cGMP levels by varying amounts. The 
ratio of the levels of cAMP/cGMP produced by activation with each 
agonist correllates very well with the tension produced. This 
suggests that the ratio cAMP/cGMP is important in the regulation of 
contractility in this muscle.
However, doubt is cast upon this theory by the results of 
experiments using sodium nitroprusside ( NP ). • It was found that 
NP ( 2 X ) caused a pronounced change in the ratio
cATlP/cGMP ( by increasing cGMP levels ), but only a small change in 
tension ( so that the tension in these experiments does not 
correllate well with the ratio cAMP/cGMP ).
In order to retain the hypothesis that cyclic nucleotides are 
important in the regulation of contractility in this preparation, 
it is proposed that some form of compartmentalisation of the cyclic 
nucleotide changes occurs ivithin the cells.
INTRODUCTION
There is at pesent a great disparity between the knowledge of the 
mechanisms of contraction of striated muscle and smooth muscle. 
The excitation- contraction coupling process in striated muscles 
has been intensively investi^ted and now it is thought that the 
fundamental processes are largely understood. However, the 
fundamental processes which regulate smooth muscle contraction are 
still only poorly understood at present. This is due in no small 
part to the great diversity of physiological and pharmacological 
properties found amongst smooth muscles as a group.
The sliding filament theory proposed by Huxley (1971 ) as a model 
of striated muscle contraction was aided by the well defined 
structure of striated muscles Such a model was not feasible in 
smooth muscle for many years, due to the lack of this ordered 
structure. With the demonstration of act in ( Hanson and Lowry 
1963 ) and, much later, myosin filaments in smooth muscles ( Kelly 
and Rice 1968 ) such a model was proposed for smooth muscle also 
( Small and Squire, 1972 ). However, althou^ this clarified the 
basic contractile mechanism, the processes involved in the control 
of contraction were still poorly understood. The major factor in 
the control of the contractile proteins was apparently the 
intracellular concentration of calcium, in the same way as for 
striated muscles. ( Bianchi 1969, Hurwitz and Joiner 1969 ) , but 
how this in turn was regulated during excitation and relaxation was 
unclear. Whereas in striated muscle the source of activator 
calcium is the sarcoplasmic reticulum, no ( or very little ) of 
this is present in smooth muscles. It became clear that, in many
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muscles, an influx ' of extracellular calcium provided much of the 
calcium necessary for activation. However, this cannot account for 
the observed properties of many smooth muscles, so intracellular
release of calcium must play an important part in many situations
( Freeman and Daniel 1973, Greenberg, long and Dieke 1973 )• This 
intracellular release of calcium may be linked to the small rise in 
intracellular calcium produced by the influx of a small amount of 
extracellular calcium by a process of calcium induced calcium
release, in a similar way as that described in skeletal muscle.
Such a process has been described in smooth muscle by Cheng 
( 1976 ). It was found that many of the pharmacological properties 
of different "types of smooth muscles could be explained in terms of 
the different relative importance of these two sources of activator 
calcium ( Deth and Van Freemen 1974 )• In addition, the dependency 
of any particular smooth muscle on extracellular calcium seems to 
correllate well with a lack of developement of structures analogous 
to the sarcoplasmic reticulum ( Devine, Somlyo and Somlyo 1972 ).
Relaxation of smooth muscles is achieved by lowering of the 
cytoplasmic calcium concentration. This is produced by either 
calcium extrusion from the cell, across the cell membrane, or by 
calcium sequestration by intracellular stores. ( Casteels, Goffin, 
Raeymakers and Wuytack 1973 )• Those muscles which utilise largely 
extracellular calcium appear to mainly pump calcium out of the 
cell, while those dependent upon intracellular calcium have calcium 
pumps located primarily on intracellular structures ( Hurwitz et al 
1973 ).
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While it became clear that calcium and calcium handling 
processes were - important in the control of smooth muscle 
contraction, the means by which these in turn were controlled was 
still unclear. In those smooth muscles which generate action 
potentials ( APs ), it was found that one of the main current 
carriers involved in the AP is calcium ( Kuriyama 1970, Tomita 
1970, Job 1969 ). This was proposed as being the major source of 
activator calcium in these muscles. It should be remembered, 
however, that many smooth muscles show a slow cyclical variation in 
the resting membrane potential, called the slow wave ( wave 
duration .5 to 5 seconds ), upon which the action potentials are 
superimposed. The slow wave is sodium dependent and may reflect 
cyclical variations in the rate of electrogenic sodium/calcium 
exchange ( Hud dart and Hunt 1975 ) • In those muscles which do not 
generate APs, a process of graded membrane depolarisation could 
still be responsible for initiating an influx of calcium which acts 
in the same manner ( Droognans, Raemakers and Casteels 1977 ). 
However, it is still possible in some circumstances for activation 
of the muscle to occur without apparent depolarisation of the 
membrane ( Su, Bevan and Ursillo 1964, Casteels, Kityaraura, 
Kuriyama and Suzulci 1977 ). This process was called 
pharmacomechanical coupling by Somlyo and Somlyo (1968). An 
example of this type of direct activation m s  shown in frog 
skeletal muscle by Saki, Geffner and Sandow ( 1970 ). They showed 
that muscles with the T tubule system disrupted by osmotic shock 
could still be activated by caffeine, probably by a direct action 
on the intracellular calcium stores. In addition to this, the 
effects of many excitatory and relaxant drugs are difficult to
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explain on this basic model of activation ( eg. phosphodiesterase 
inhibitors etc. )
These difficulties led to the concept that smooth muscle 
contraction could be controlled, at least in part, by some "second 
messenger" within the cell. The first substance to be proposed for 
this role was cAT4P, which was first suggested as being involved in 
muscle relaxation ( Bar 1974, Anderson 1972 ). It was proposed
that cAMP could act to stimulate the calcium removal processes 
responsible for lowering the cytoplasmic calcium concentration and 
so cause relaxation. This hypothesis could account for the action 
of relaxant drugs such as phosphodiesterase inhibitors, -vdiich raise 
cAMP levels ( see Bar 1974 ) • Only a few inconsistent results have 
been quoted, for example caffeine has been shown to induce 
relaxation in mammalian smooth muscles, but this is preceded by a 
contraction in guinea pig taenia coli ( Ito and Kuriyama 1971 ).
This concept was soon extended to include the involvement of 
second messenger substances in the control of contraction also, 
althou^ cAMP seems to be unimportant in this respect, it appeared 
that another cyclic nucleotide, cGMP, was involved in the control 
of contraction. cGMP changes induced by agonists and many drugs 
were found to occur in many instances, usually a rise associated 
with contraction. Thus it appeared that smooth muscle contraction 
could be controlled by the changes in either cAMP or cGMP. A rise 
in cAMP would be associated with relaxation and a rise in cGMP with 
contraction. This idea seemed to fit well with the proposed
actions of these cyclic nucleotides in many situations, the so
PAGE 5
called Ying/Yang hypothesis proposed' hy Goldberg et al. 
( Goldberg, Haddox, Ni col, Glass, Sanford, Keuhl and Es tens en
1975 ).
It soon became apparent that this idea was an over 
simplification of the situation, however. In many cases it could 
be shown that the changes in cAMP and/or cGî4P could be dissociated 
from the changes in contractility ( Diamond and Janis 1978,1980, 
Diamond and Hartle 1974 ). For example, in many muscles
contraction is associated with a rise in cGMP levels. However, 
many relaxant drugs were shorn to cause a rise in cGMP levels also, 
eg. sodium nitroprusside, ( NP ). A further complication arose 
when it \?as shown that, although the changes in cGMP induced by
agonists are dependent upon extracellular calcium, the changes 
induced by NP are not ( Schultz, Hardman, Hurwitz and Sutherland 
1973, Schultz, Schultz and Schultz 1977 )•
In order to circumvent these difficulties a modification of 
this theory has been proposed. In this it is assumed that the 
important regulatory changes in cyclic nucleotides take place in 
some small compartment within the cell. These changes are thou^t 
to be impossible to detect against the background of the gross 
changes occurring in the cell as a whole. Such a
corapartmentalisation has been proposed by various workers.
It has been shown that cyclic nucleodides are important in the 
regulation of calcium handling mechanisms ( Nilsson and Andersson 
1977 )• A role proposed for cyclic nucleotides on this basis is
I
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that cGMP, at least, could act as a negative feedback signal, to 
regulate cytoplasmic calcium concentration ( Schultz, Hardman, 
Schultz, Baird and Sutherland 1973 )•
Cyclic nucleotides have also been implicated in the control of 
many metabolic processes in smooth muscle. In particular, it has 
been demonstrated that there is a cAMP dependent protein kinase 
which can phosphorylate Myosin Li^t Chain Kinase ( MLCK ), thus 
rendering it inactive ( Adelstein, Conti, Hathaway and Klee 1978 ). 
This data supports the view that cAMP is important in the 
relaxation of at least some smooth muscles. Another possibility is 
that cyclic nucleotide changes are responsible for ensuring that 
the appropriate metabolic changes are stimulated concurrently with 
contraction.
Recently much work has been done on the biophysics and 
biochemistry of smooth muscle contraction, which has led to a more 
complete understanding of this process. The contractile proteins 
are unlike those of striated muscle, in that there is no troponin C 
like component in smooth muscle ( Driska and Hartshorne 1975 ). 
Instead, contraction is initiated by phosphorylation of Myosin 
light chains, by MLCK. MLCK activity is regulated in turn by a 
calcium dependent modulator protein, called calmodulin. It is this 
calcium dependency #iich conférés calcium sensitivity on the 
contractile mechamism as a whole. Many drugs have been found to 
act at this stage in the activation process, eg. triflouroperazine 
( Stelazine ) is thought to prevent the activation of MLCK by 
calmodulin ( Cassidy, Hoar and Kerrick 1980 ).
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The aim of this work was to investigate some aspects of the 
excitation- contraction coupling process in the rat anococcygeus 
muscle.
The rat anococcygeus muscle was introduced as a preparation 
for the study of smooth muscle physiology and pharmacology by 
Gillespie, ( Gillespie 1972 ). It has several properties which act 
in its favour in studies of this kind. The muscles contain little 
connective tissue and are in the form of thin ( 300um ), flat 
sheets, with an in situ length of approx 3cm. and width of approx 
5mm. This mimimises the geometrical problems associated with the 
use of smooth muscles from the walls of hollow viscera. In 
addition, the diffusion pathway for drugs and oxygen, etc. is 
minimised. The muscles are easily isolated.
Althou^ it is associated id.th the alimentary tract, the 
pharmacology of the rat anococcygeus differs from that of visceral 
smooth muscle, in that it will contract in response to 
noradrenaline, acetyl choline, 5 HT and KCl depolarisation. The 
muscle has a dense adrenergic innervation, demonstrated by 
Palck/Hillarp staining, ( Gillespie and Lullman- Rauch 1974 ), 
which, upon stimulation of the extrinsic nerves, causes a 
contraction. In addition, there is a nerve supply which will 
produce relaxation when the muscle tone has previously been raised. 
The transmitter responsible for this has not been identified.
Electrophysiological studies have shown that the rat 
anococcygeus does not produce spontaneous activity and does not
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normally generate action potentials ( APs ) ( Creed 1975 )•
Stimulation of the extrinsic, excitatory nerves, or the addition of 
stimulating agents produces a graded depolarisation of the membrane 
( Creed, Gillespie and Muir 1975 ). The muscle is classified as 
multi unit in the classification proposed by Bozler. ( Bozler 
1948 ).
The excitation contraction coupling mechanism was investigated in 
this study from three main standpionts.
a) The mechanical responses of the tissue to three 
agonists, NA, ACh and KCl, under different conditions 
and the effects of some antagonists on these.
b) The changes in cyclic nucleotide levels in the 
muscles associated with contraction induced by each 
of the three agonists and the influence of various 
proceedures on these.
c) The electrophysiological response of the muscle 
to various agents, measured with intracellular 
microelectrodes.
The data from all three aspects of this study were ^thered 
together in the hope of obtaining a more complete picture of the 
mechanism of excitation contraction coupling in the rat
anococcygeus, and how this mi^it relate to the results of similar 
studies on different muscles.
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METHODS
1.0 MECHANICAL STUDIES
1.1 General
Throu^out this study male Wistar rats of wei^t 350-400g were 
used. The anococcygeus muscles were dissected out using a method 
described by Gillespie (1972). The animal was stunned and killed
by exsanguination. The abdomen was opened in the midline and the 
pelvis split. The bladder was moved to one side to allow access to 
the colon and anococcygeus muscles. The two anococcygeus muscles 
arise from the upper coccygeal vertebrae close to one another, 
dorsal to the colon. They then pass caudally, lying first behind, 
then alongside, the colon. The muscles finally join to form a 
ventral bar in front of the colon, a few mm. from the anus. The 
colon was raised and the ‘anococcygeus muscles located in the 
connective tissue on each side. I^ch muscle was then freed from 
this and a loop of thead passed round it near to the ventral bar. 
This was used to secure a silver chain to the muscle. The ventral
bar was then cut, so freeing the ventral end of the muscle. A 
further loop of thread was used to secure a silver wire loop to the 
muscle, as near to the coccygeal origin as possible. The muscle
was then cut just dorsal to this and lifted free. Both muscles
were similarly prepared and suspended vertically in a single organ 
bath between hooks formed on the side of the organ bath and the 
tension transducers ( single bridge isometric tranducers, 0-1OOg,
Dial  G a u ge s
Transducer  1 Tra ns d uce r  2
37"C Suction
" o
3 7 ' C “^ Gas in
D r a in  andRefill
Fig M1 Apparatus.
Diagramatio representation of the apparatus for mechanical studies. The muscles are suspended in pairs between two fixed hooks on the sides of the bath and two Isometric tension transducers. These are mounted on a rack and pinion arrangement ( not shown ) which allows them to be moved vertically, in order to maintain a constant resting tension on the muscles. The Increments of length are monitored by the dial guages.
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supplied by Devices ) ( see fig. Ml ). The bathing medium was 
Krebs solution, gassed with 95^ 0^/ %  COg. The composition of 
the Krebs solution varied according to the experimental protocol 
followed. The composition of the various solutions used are shown 
in table (M1 ). In all experiments using Ach or KCl as the agonist, 
phentolamine ( 10“^M ) was routinely added to the Krebs solution. 
This is necessary to prevent the effects of any noradrenaline which 
may be released from nerve terminals by either of these agents. 
Isometric tension changes were recorded by the transducers and 
displayed on a pen chart recorder. The system was calibrated by 
hanging waists from the transducer in the range 1-1 Og. In all 
experiments the muscles were maintained at a resting tension of 1g. 
Generally the muscles exibited stress relaxation throughout the 
course of the experiment, so that the length had to be increased to 
maintain this resting tension. Typically this change in length was 
of the order of 1 .5 to 2 mm. in a muscle of overall length 10 mm. 
( ie. about 15 to 20 ?^ ). To facilitate this, each transducer was 
mounted in a vertical rack and pinion arrangement. The incremental 
changes in length were monitored by dial gauges mounted as in fig. 
Ml . The length of each muscle was measured to +/- 0.1mm. using a 
vernier microscope, sitting through the side of the orggm bath. 
At the conclusion of the experiment the muscles were weired. The 
silver chain and loop were removed by cutting the muscle as near to 
the knot as possible with à new scalpel blade. They were then 
dried of surplus surface moisture by dabbing gently onto filter 
paper and weighed to +/- 0.01 mg. This process was repeated three 
times and the weight taken as the mean of these.
Assuming a density of 1 .Ogcm“^ for the muscle, ( values
Table M1 Krebs solutions.
Composition of the modified Krebs solutions used.
en
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quoted "by Carlson and Wilkie (1974) are 1.05 to 1 .05 for typical 
muscle ), ( Carlson and Wilkie, 1974 ); the volume of each muscle 
can then be calculated from the wei^t. Since the muscle is fairly 
uniform in thickness and width, the cross sectional area is 
obtained, to a good approximation, by division of the volume by the 
length.
1.2 Log dose response curves of Agonists.
Paired muscles were dissected out and set up as above. When a 
stable resting tension of 1g. had been obtained the agonist 
( either noradrenaline, (WA.), acetyl choline, ( Ach ), or 
potassium chloride, ( KCl ) was added to the bath, starting at the 
lowest dose. After each dose the bath was washed three times 
( over a period of 10 minutes ), The drugs were added in 0.9^ 
saline, the added volume never exceeding 1ml. (in order to 
minimise changes in the ionic composition of the Krebs solution. ) 
The bath volume was 20ml. Log dose response curves were 
constructed using the data from several muscles. The -log ED50 was 
calculated for each curve using probit analysis.
The effect of adding 1ml. of 0.9^ saline to the bath was 
checked and found to produce no significant response. The addition 
of hyperosmolar solutions to the bath can affect the response of 
the muscle. This phenomenon has been investigated by McKnight. 
( personal communication ). He found that the addition of 
hyperosmolar solutions of either sucrose or NaCl produced a slight 
rise in tone in resting muscles. The threshold for this effect was 
25mOsmol, with a maximum of 1 -5g rise in tone produced by 40Qm0smol
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solutions. The only hyperosmolar solution used in this study was 
KCl solution, usually 8QmM, This solution would therefore he 
expected to produce a rise in tone of around 0.5g ( equal to about 
6 to 7 Nm~^ for typical muscles ). The addition of 80mM KCl 
produces an active tension increase of about 80 Nm , so the 
error introduced by the effect of the hyperosmolarity of the 
solution is approximatly 7-8
1.3 Antagonist dose response curves
The muscles were set up and stabilised in normal Krebs as 
before. The maximal dose of agonist was repeated until a 
reproducible response was obtained. An increasing dose of 
antagonist was then added 10 minutes prior to each maximal dose of 
agonist. This process was repeated for each of the three agonists 
in combination with four antagonists, ( Nitroprusside, Verapamil, 
Stelazine, and Theophylline ). The results of several experiments 
were combined to produce a series of antagonist dose response 
curves. The results of these experiments were used to determine 
the concentrations of antagonists used in later experiments.
1.4 Separation of the phases of contraction
It was noticed that contractions produced by M  and Ach, which 
are normally a single contraction, become bi-phasic at low calcium 
concentrations. In contrast, the contraction produced by the 
addition of KCl to muscles in normal Krebs is always bi-phasic.
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Calcium 45 studies with both single unit and multi unit muscles 
have shown that the two phases of this type of contraction in other 
muscles may utilise different sources of activator calcium ( Saad 
and Huddart 1981 )• Possible differences in the pharmacology of 
the two phases of these bi-phasic contractions were investigated 
therefore, in order to determine if they are produced by different 
mechanisms in the rat anococcygeus.
The muscles were set up and stabilised in calcium free Krebs 
as for the calcium dose response curves. The Krebs solution was 
then changed for one containing low calcium ( 0.12 mM ) This
concentration was chosen on the basis of the calcium dose response 
curves as the highest in which Ach and M  produced distinctly 
bi-phasic contractions. The maximal dose of the agonist was 
repeated until the response was stable in this low calcium
concentration. The effect of increasing concentrations of 
antagonists on this contraction was then investigated ( An 
"antagonist dose response curve" ). An increasing concentration of
the antagonist was added 10 min prior to each maximal dose of
agonist. Curves so produced were plotted seperately for the 
primary and secondary components of the contraction.
As before, in experiments using Ach or KCl, Phentolamine
( 10"% ) was added to the Krebs solution.
1.5 Calcium Dose response curves and Calcium washout curves.
A dose of each agonist was selected , on the basis of the log 
dose response curves for the agonists, which gave a "just maximal" 
response. These doses were;
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NA 2.5 X 10“  ^ M
Ach 2 X 10”^ M
KCl 80 mM.
This dose of agonist was added repeatedly until a reproducible 
response was obtained, ( typically three additions ), with the 
muscles in normal Krebs solution. This was then replaced with 
nominally calcium free Krebs, produced by omitting calcium from the 
solution. EDTA. or other chelating agents were not used. The 
dose of agonist was then repeated at intervals of 2 min, 10 min, 18 
min and 26 min after the chan^, with two washes between each. The 
results obtained were used to produce calcium washout curves for 
each agonist.
When the response of the muscles was reduced to the minimum 
possible by the calcium free Krebs, ( shown by repeated doses of 
agonist ), the calcium dose response curve ivas started. Calcium 
chloride was added in solution using micropipettes to give a bath 
concentration in the range 15 uM to 6.4 mM. The calcium was added 
10 minutes prior to the addition of the agonist.
Where the contractions were distinctly bi-phasic ( eg. the 
contraction produced by M  in low calcium concentrations ), the two 
phases were measured seperately and curves produced for both 
primary and secondary phases.
These curves were also produced against a baclîground 
concentration of verapamil or nitroprusside in order to assess the 
effects of these agonists. The antagonists were added to the Krebs 
solution before the experiment to give concentrations of 2x10"% 
for nitroprusside and 5x10"*% for verapamil. These 
concentrations were chosen on the basis of the antagonist dose
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response curves (see section 1.3)'
1.6 Drugs added during the Plateau Phase of contraction.
Some pilot experiments were performed in order to asses the 
effects of antagonists added during the plateau phase of the 
contraction produced by each agonist. The muscles were set up and 
stabilised in normal Krebs as above. The maximal dose of the 
agonist was then added and the contraction allowed to continue for 
an extended period ( 30 min.). This was to assess whether the
contraction was well maintained. The bath was then washed out 
three times and the dose repeated. During the plateau phase of 
this contraction, (after about 15 min), the antagonist under 
investigation was added to the bath. Antagonists used were
Nitroprusside (NP) and Verapamil (V).
1.7 Addition of Agonists
Some experiments were done in which two or more agonists were 
added to the bath conceoutively. In this case the response to the 
maximal dose of the first agonist was stabilised as before. The 
dose was then repeated and at the desired time during the 
contraction ( usually at the peak of the plateau phase ) the 
maximal dose of the second agonist was added .
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2.0 CYCLIC NUCLEOTIDE STUDIES
2.1 General
The changes in cyclic AMP (cAMP) and cyclic GMP (cGI^ ÎP) during 
contractions produced by each of the three agonists, (NA), (Ach) 
and (KCl), were investigated. The apparatus was modified as in 
Fig. M2. Muscles were set up singly and the maximal dose of the 
appropriate agonist added to the bath. The progress of the 
contraction was monitored as before on the pen chart recorder. 
When the maximum tension had been reached, the whole bath was 
lowered to expose the muscle. This was frozen as quickly as
possible by freeze clamping with forceps cooled in liquid nitrogen. 
The silver chain and silver wire loop were detatched and the 
muscles stored in liquid nitrogen. In order to obtain enough 
tissue for the cyclic nucleotide assays, it was necessary to pool 6 
to 8 muscles for each determination. Control levels of cyclic 
nucleotides were determined by setting up the muscles at a resting 
tension of 1g. for 15 minutes before freezing, ( approximately the 
length of time taken for the stimulated muscles to reach maximum 
tension ).
The time taken to actually freeze the muscles was usually 
about 30 seconds. This was the time taken to lower the bath from 
the muscle, freeze clamp the muscle with pre-cooled forceps, and 
then detatch it from the tranrsducer and the support. The muscle 
has then to be freed from the silver chain and loop and placed in 
small plastic vials for storage in liquid nitrogen. The main
Fig M2 Modified apparatus for Cyclic Nucleotide studies.
The apparatus is arranged as in Fig Ml, except that only one muscle is used. The fixed hook on the side of the organ hath is replaced by one which is supported outside the bath, so that the bath as a whole can be lowered away from the muscle, which can then be freeze clamped.
D i a l  Gauge
Transduce r S u p p o r t
Suet ion
37'C G a s  in
Drai  n and
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criticism of the procédure is that the time taken to actually lower 
the bath and freeze the muscle is too long and may be quite
variable. However, it was felt that the time-constraints on this
stage of the-experiment were not too severe. The muscle contracts 
only very slowly, and maximum tension is maintained for a 
considerable length of time. If a time-course study were 
attempted, in which the changes in cyclic nucleotide levels on a 
minute by minute basis were important, the method would probably 
not be satisfactory as it stands. However, the present study 
attempted to measure the levels of cyclic nucleotides at the time
of maximum tension production, which is generally 15 to 20 minutes
after stimulation, and is maintained for an extended period of 
time. Under these conditions the above procedure was felt to be 
adequate.
2.2 Extraction
Each group of muscles was crushed in a brass motar and pestle 
cooled in liquid nitrogen. The crushed tissue was then extracted 
with about 2ml. of acidified ethanol (100ml. ethanol + 0.1ml. 
10M. HCl) for 5 minutes at 0°C. During this time the extract
was vortex mixed three times. The extract was then centrifuged
(2,000rpm. for 5 min.) and the supernatant decanted off. The
pellet was then re-extracted in the same way. The supernatants 
were combined, warmed to 45% in a water bath and the ethanol 
blown off in a stream of nitrogen. The dry extract was then 
re-dissolved in 0.5 ml. of Tris/EDTA buffer (supplied with the kit 
-see later ) This solution was then assayed for cyclic nucleotides.
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The pellet produced was assayed for protein content using the 
Biuret method (see later —  section 2.5 )•
In each extraction performed a recovery check was included. 
In this a mixbure of 10 mg. Albumin and 10 pmol of cAMP was 
extracted in the same way as the muscles.
The results of these recovery checks were usually 51 to 56^
protein recovery and 75 to 80^ cyclic nucleotide recovery. If in
any assay the results of the recovery checks were not consistent 
with those usually obtained, the results of the assay were 
discarded. No correction for variations in the results of the
recovery checks was attempted.
The extraction stage produced unsatisfactory results 
initially. At first the extraction medium used was 100ml ethanol + 
1.0ml of 1M HGl. This was found to produce very low protein 
recoveries ( around J>Ofo for albumin ) and that the results for the 
cAMP assays in these experiments was very variable, although the 
cGMP assays were fairly reproducible. The extraction medium was 
changed to 100ml ethanol + 0.1ml of 10M HCl. It was found that
this gave much hi^er protein recoveries ( around 55/^  ), and the 
cAMP results became much more reproducible. It is suggested that 
the more aqueous extraction medium was producing greater "carry 
over" of proteins into the cyclic nucleotide fraction. Since the 
cAMP assay is a protein binding assay, it seems reasonable to 
suggest that this extra protein may, in some way, have interfered 
with the binding of cAMP in the assay. cGMP would not be affected 
so much, since it relies on the much more selective binding to a 
specific antibody. In connection with this problem Theobold, Syson
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and Burrin ( 1978 ) used trypsin to remove contaminant peptide 
factors from the assay. However, they used a different extraction 
proceedure ( boiling EH^PO^ solution ). In view of the 
reproducible results obtained in this study using ethanol 
extraction, this was felt to be uneccessary.
2.5 Cyclic Nucleotide Assay
Cyclic nucleotides were assayed using kits supplied by 
Amersham Ltd. cGMP was assayed by Radio-immune assay. This assay 
is based on the competition between unlabelled cGMP and a fixed 
quantity of tritium labelled cGMP for binding to an antiserum which 
has a hi^ specificity and affinity for cGMP. The amount of 
labelled cGMP bound to the antiserum is inversely related to the 
amount of cGHP present in the assay sample. The assay is carried 
out by incubating a fixed amount of the solution to be assayed 
( 100ul ) with a known amount of tritium labelled cGMP and a fixed 
amount of the specific antibody ( Incubation is for 2 hours at
o°c ).
Zero dose incubations were carried out by substituting 100ul 
of Tris-EDTA buffer for the assay sample. Blank reagent is 
supplied with the kit. This has a very high affinity for the 
specific binding sites of the antibodies and displaces cGW 
completely from them. This can therefore be used to produce blank 
( ie. no binding of cGMP ) incubations. Standard solutions were 
used to produce a calibration curve in the range 0.5 to 8 pnol. 
After incubation the protein was separated out by precipitation by
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the addition of ammonium sulphate solution ( 60^ saturated ), 
followed hy centrifugation in a refrigerated centrifuge. ( MSE 
coolspin ) The supernatant \ra.s then decanted off and the protein 
re-dissolved in 1.1 ml of water. 1 ml. samples of this were taken 
for liquid scintillation counting. The counts for the blank, zero 
dose and standard solutions were used to produce a calibration 
curve from which the amount of cGMP in the assay sample can be 
read. All the incubations were performed in duplicate.
Specificity; in view of the specificity quoted by Amersham as 
shown below, cross reactivity with other nucleotides was not 
considered to be a problem in this study.
Nucleotide cGMP cAMP AMP,ADP,ATP GMP,GDP,GTP
pmol per assay
tube to give 0.8 120,000 >10 6 approx. 25,000
50^ inhibition
cAMP was assayed using a specific protein binding assay. This 
is similar to the cQ^ IP assay, except that the competition between 
unknown amount of unlabelled cAMP and fixed amount of tritium 
labelled cAMP is for binding to a specific binding protein, rather 
than an antibody. The amount of labelled cAMP bound is inversely 
related to the amount of unlabelled cAMP present.
The method suggested in the kit was modified sli^tly to 
improve the sensitivity of the assay. lOOul samples ( instead of
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the 50ul suggested ) of the soulution to he assayed were incubated 
with a known amount of tritium labelled cAMP and a fixed amount of 
specific binding protein. Blank determinations were made by 
substituting buffer for both the unknown solution and the labelled 
cAIIP solution. All tubes other than those with assay sample had an 
extra 50ul of buffer added to them to compensate for the increase 
in overall volume ( due to adding 10Oul of assay sample rather than 
the 50ul suggested ). After incubation at 0 %  for 2 hours the 
free nucleotide iras removed by the addition of lOOul of ice cold 
charcoal suspension, vortex mixing briefly and centrifuging in a 
refrigerated centrifuge. 250ul samples { as opposed to the 200ul 
in the unmodified procedure ) of the supernatant were then taken 
for liquid scintillation counting. The counts for the standards 
and the blank were then used to produce a calibration curve, from 
which the amount of CAMP in the assay samples was read.
The results of the assay of a solution of known concentration by 
the standard and by the modified procedure were compared. It was 
found that the modification did not affect the calibration of the 
assay.
Specificity; the data quoted by Amersham ltd. give the 
specificity of the assay as follows; ATP does not cross react at 
concentrations up to 5niM. This is approximatly a million fold 
excess over the amount of labelled cAMP present. An approximatly 
200 fold excess of cGMP is required to give 50^ inhibition of 
binding. Although this assay is therefore not as specific as the 
cGMP assay, cross-reactivity with other nucleotides was not 
considered to be a problem.
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2.4 Liquid scintillation coimting
Samples from the cyclic nucleotide assays were counted in a 
Packard Model 3320 liquid scintillation counter. The counting time 
was 10 minutes. The samples from the assays were counted in 10ml 
of scintillant made up as follows;
Triton X 100 = 666 mis 
Scintol 2 = 1 0 0  mis
Toluene to 2 litres.
Scintol 2 (a toluene based scintillator, E max 430nm.) was obtained 
from Koch-Light. The samples taken from the cAMP assay were made 
up to 1ml by the addition of 750ul of water, to ensure that, as 
with the cGMP assay, the total aqueous content of each vial was 
approximatly 9^ of the total volume. This has been shown to 
produce a clear homogeneous mixture which remains stable at both 
room temperature and at 4%, the temperature at which the vials 
were counted. A father advantage of using this scintillant, rather 
than the more commonly used 1 :1 Toluene:Triton X mixture, is that 
the 2:1 mixture has a much lower vicosity. This allows the more 
rapid clearing of trapped air from the mixture. ( trapped air can 
lead to unpredictable variations in counting efficiency ) To 
minimise the effects of changes in counting efficiency produced by 
changes in temperature, the vials were left to equilibrate in the 
counter for 60 minutes before counting. This period of dark 
adaptation also serves to reduce the residual photo-excitation of 
the scintillant due to exposure to sunli^t or flourescent lights.
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2.5 Protein Assay
The pellet left from each extraction was assayed for protein 
using the Biuret test. Biuret reagent was made up as in Appendix 
A.
1 ml. of water was added to each assay tube and the pellet broken 
up by vortex mixing. To this was then added 4 ml. of Biuret 
reagent and the tube vortex mixed again. The tubes were then 
allowed to stand for 30 min. at room temperature, during which 
time they were vortex mixed a further three times. A calibration 
curve was constructed using serial dilutions of a solution of 
Bovine serum albumin, over the range 0.5 to 10mg, protein per ml. 
The absorbance of the solutions was read at 550 nm. in a Unicam SP 
1800 spectrophotometer. Each result was taken as the mean of three 
readings.
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3.0 ELECTROPHYSIOLOGY
3.1 General
Intracellular recordings of membrane potential of the rat 
anoccocygeus muscles were obtained using glass micro-electrodes. 
The muscles were dissected out as before, except that the silver 
chain and wire loop were not attatched. Instead the ventral end of 
the muscle was left free, while the dorsal end had a small loop of 
thread attatched to it. The muscles were mounted singly in the 
bath as shown in fig. M3. The ventral end of the muscle was
pinned flat to a Sylgiard base and the dorsal end attatched to a
tension transducer by the loop of thread. Tension was not 
monitored accurately in these experiments, so the compliance of the 
thread as compared to silver chain did not create a problem. 
Rather, tension was monitored as a means of assesing tissue 
activity and to indicate when maximum tension had been reached.
In order to minimise movement of the muscles when stimulated
(which creates problems of eletrode breakage etc.), the muscles
were set up at a resting tension of in these experiments.
Krebs solution entered the bath after being pre-warmed to 37% by 
a heat exchanger. The bath itself was also warmed to 37% by 
circulating water. The temperature of the bath was monitored using 
a digital thermometer. Krebs solution was continously removed from 
the bath by suction from a well at the opposite end to the inflow. 
The surface of the solution in the bath does not comunicate with 
this well, so greatly reducing electrode movement due to ripples
Fig M3 The Electrophysiology Bath.
Muscles are pinned out singly on the Sylguard well as shovm. The temperature prohe is a small diode which signals temperature changes as changes in junction potential. The hath is maintained at 3 1 °  G by a water jacket.
reference 
elect rode37°C
suction
Krebs in
temperature
probe
Sylguard well
Transducer
suctionelectrode
muscle pinned out
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produced by the suction. In this way a continous perfusion of the 
bath is mintained. Doses of agonists were injected into the 
inflow end of the bath by syringe. The actual concentration of the 
agonist over the muscle is therefore a complex product of diffusion 
and the flow throu^ the bath. The dose of each agonist used was 
therefore decided on an empirical basis, as the minimum dose 
necessary to give a well maintained, maximal contraction. The bath 
volume was 10 ml. The Krebs solution was ^ised with 
95^ Og / 5^ COg, both in the resevoir and in the bath.
3*2 Electrodes
Electrodes were pulled using thin walled capillary ^ass 
tubing obtained from Clarke Electromedical Instruments ltd. These 
were filled with 1 M. potassium acetate. Electrodes in the 
correct resistance range ( 20 to 35 megohm ) could be obtained 
routinely. The main problem was in filling the electrodes 
properly. The techniq^ ue adopted was to fill the electrodes as well 
as posible from a syringe, with a millipore filter attatched. The 
electrodes were then placed vertically in a covered beaker, with 
their tips immersed in 1M potassium acetate overni^t. Before use 
each electrode was examined microscopically for bubbles, dirt or 
damage. Each one was, then measured electrically and discarded if 
the resistance was not in the range 20 to 35 megohm. Usually about 
1/3 of the electrodes proved to be servicable.
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3.3 Recording System
Tension and membrane potential were recorded simultaneosly. 
Tension changes were recorded by the transducer and displayed on 
one channel of a dual beam storage oscilloscope and also on a 
Devices heated pen chart recorder. Potential changes from the 
electrode were recorded using a Neurolog pre-amplifier ( ^ i n  1:1 ) 
and the output of this fed to the other channel of the
oscilloscope. Photographs were taken of both membrane potential 
and associated tension changes directly from the oscilloscope, 
while the continuous record of tension changes on the chart
recorder provided a useful glide to the tissue viability throughout 
the experiment. Calibration of both recording systems was carried 
out before each experiment. The tension transducer was calibrated 
by hanging weights vertically from it in the range 1 to lOg. The
potential recording system was calibrated using a lOmY signal,
which can be generated by the’ pre-amplifier for this purpose.
Due to the small size of the smooth muscle cells in this 
tissue (approx. 10 urn. diameter x 100 um. length) ( Gillespie 
and lullman- Rauch 1974 ) it was found to be extremely difficult to 
maintain intracellular recording for any length of time (usual time 
in one cell being of the order of 10-30 seconds) This made it 
impossible in most cases to obtain recordings of the change in 
membrane potential caused by the action of an agonist, especially 
since the movement of the tissue when stimulated usually caused the 
electrode to be dislodged. The tecnique adopted, therefore, was to 
record membrane potentials from a sample of cells in the control
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situation, then to add the agonist and, when the tension was near 
maximal, to record from another sample of cells. To enable the 
recordings to be as objective as possible, certain criteria were 
adopted as to which penetrations should be included in the sample. 
Penetration of the cells could only be judged by the potential 
recorded as the electrode was advanced throu^ the tissue, not by 
visual means. A good penetration was judged by the following 
criteria;
(1 ) On advancing the electrode the recorded potential drops 
suddenly upon penetration of a cell ( a vertical step in the 
trace ).
(2)The potential recorded remains reasonably steady and noise 
free for at least 10 seconds.
A trace showing a cell penetration which meets these criteria 
is shown in Fig R9-1 .
The electrode resistance was checked after each attempted 
penetration, sucessful or otherwise. The electrode was discarded 
if the resistance had changed significantly (indicating a blocked 
or broken electrode).
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RESULTS
1.0 MECHANICAL STUDIES.
1 .1 Log Dose Response Curves of Agonists.
The log dose response curves of the muscle , to each of the 
three agonists are shown in Eig R1 . It can he seen that the 
maximum response to each of the agonists is very different , being 
165.6 [ SE=8.5 ], 85.6 ( SE=6.8 ) and 65-7 ( SE=6.3 ) Nm”^ for 
NA, ACh and KCl respectively. The corresponding -log ED50 values 
are 5*6 , 4.1 and 3-1•
1.2 Antagonist Dose Response Curves.
Antagonist dose response curves are shown in Pigs. R2-1 to R2-12. 
The rational behind obtaining these curves was;
a) To investigate possible differences in the sensitivity of 
each of the three agonists to sodium nitroprusside, Verapamil, 
Stelazine and theophylline, thus clarifying the ways in viiich the 
three agonists produce a response.
b) To investig^,te possible differences between the different 
phases of contractions produced by the three agonists. The 
contraction produced by KCl is bi-phasic in normal Krebs, but the 
contractions produced by NA and ACh are only bi-phasic in low 
calcium Krebs. The curves for the primary phases of NA and ACh
Pig R1 Log Dose Response Curves for Each Agonist.
Curves for each agonist are shown on the same scale. Error bars = 1SE. No error bars are shown where they are too small to represent accurately.
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contractions were therefore obtained in low calcium ( 0.12mM ).
1.2.1 Curves in normal calcium solution; Sodium nitroprusside and 
Verapamil -
It can be seen that the dose response curves obtained in 
normal calcium ( Pigs B2-1 to R2-4 ), show marked differences 
between the three agonists. The contraction produced by M  appears 
to be largely unaffected by concentrations of V or EP up to 10""%
( no significant antagonism compared to control levels ) The 
contractions produced by KCl and ACh, however, show marked 
antagonism by both NP and V. In the case of KCl both phases are
inhibited by both NP and V, the greatest inhibition being produced
by V in both cases. V ( 10"*% ) produces an inhibition of about
93^ on the primary contraction, and about the same on the
secondary. NP ( 10"% ) has different effects on the two phases, 
producing about 30^  inhibition of the primary and a sli^tly 
greater inhibition of the secondary ( about 45^ )•
Ach induced contractions are also markedly inhibited by both 
NP and V, but in this case the greater antagonistic effect is 
produced by NP, V ( 10"% ) producing about 60^ inhibition and NP 
( 10"% ) producing about 75^ inhibition ( althou^ in this case 
the significant difference between the two curves is less 
pronounced, due to the greater errors in the curves themselves, 
since the contractions produced by ACh tend to be more variable 
than those produced by the other agonists ).
Fig R2-1 Antagonist Dose Response Curves; M  (NP and V).
The figure shows the effect of an increasing dose of Verapamil ( open circles ) and Nitroprusside ( filled circles ) on a contraction induced^ , by a constant, maximal dose of NA ( 2.5 x 10 %Point labelled "Control" is the response with no antagonist present. Error bars = 1SE. n = 8 for each point.
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Fig R2-2 Antagonist Dose Response Curves; KOI (primary), (NP and V).
As for Fig R2-1, except that the response measured is the primary phase of a contraction induced hy KCl ( SQfflM ).
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As for Pig R2-1 , except that the response measured is the secondary phase of a contraction induced by KCl ( 80mM ).
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Pig R2-4 Antagonist Dose Response Curves; ACh (KP and V).
As for Pig R2-1, except that the response measured is the contraction induced by ACh ( 2 x 1 0 %  ).
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1.2.2 Curves in normal Calcium; Stelazine and Theophylline. -
The inhibition produced by Stelazine and Theophylline is shown 
in Pigs R2~5 to R2-8. The effect on the primary and secondary 
phases of the KCl contraction are so similar that the curves for 
both phase are identical. In both cases Stelasine has a greater 
inhibitory effect than Theophylline. This greater inhibition by 
Stelazine is also shown in the case of HA and ACh, althou^ the 
difference in the antagonist potency is not so great in the case of 
ACh. This is illustrated by the potency ratio of the ED50
( concentration giving 50^ inhibition ) for Stelazine and 
Theophylline, as shown below.
Doses giving 50^ inhibition; (Mol)
Theophylline Stelazine Ratio Theo/STZ
NA 5.0 X 10"^ 1.8x10“^ 28
ACh 1.5x10"^ 2.2 X lO"^ 7
2.4 xicr5 6.0 Xicr5 40
Note that it is not possible to use concentrations of . 
Theophyline greater than 5 X 10"%, because of its low solubility 
in water.
1.5 Separation of Phases;
Antagonist dose response curves in low Calcium.
Pig R2-5 Antagonist Dose Response Curves; NA (STZ and Theo).
The effect of an increasing dose of STZ ( open circles ) and Theo ( filled circles ) on a contraction induced by a constant, maximal dose of NA ( 2.5 X 10"% ). Error bars = 1SE. n = 8 for each point.
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Pig R2-6 Antagonist Dose Response Curves; KCl (primary), (STZ and Theo).
As for Pig R2-5y except that the response measured is the primary phase of a contraction induced by KCl ( 80mM ).
Pig R2-7 Antagonist Dose Response Curves; KCl (secondary), (STZ and Theo).
As for Pig R2-5, except that the response measured is the secondary phase of a contraction induced hy KCl ( 80mM ).
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Fig B2-8 Antagonist Dose Response Curves; ACh (STZ and Theo).
As for Fig R2“5, except that the response measured is the contraction induced hy ACh ( 2 x 10 %  ).
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Fig R2-9 Antagonist Dose Response Curves in Low Calcium; M  (primary)
The effect of an increasing dose of Verapamil ( open circles ) and Nitroprusside ( filled circles ) on the primary phase of a contraction induced hy a constant, maximal dose of NA ( 2.5 x 10 M ) in low calcium solution ( 0.12mM ). Error bars = 1SE. n = 8  for each point. The point marked "Control" shows the response with no antagonist present.
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Pig R2-10 Antagonist Dose Response Curves in low Calcium; NA (secondary).
As for Pig R2-9, except that the response measured is the secondaryp-phase of the contraction induced by m  ( 2.5 X 10 ).
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Fig R2-11 Antagonist Dose Response Curves In Low Calcium; ACh (primary).
As for Fig R2-9, except that the response measured is the primary phase of the contraction induced hy ACh ( 2 X 10 ).
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1 .3*1 - Pigs R2-9 to R2-12 show the dose response curves of
the inhibitory effects of V and EP on the primary and secondary 
phases of contractions produced by NA and ACh in low calcium Krebs 
( 0.12mM ). In the case of NA a significant difference in the 
inhibition of the two phases is apparent. The secondary phase is. 
inhibited to a large extent by both NP and V, V having the greatest 
effect. V produces a maximum inhibition of 80^ at about 8 x 
10"%; whereas NP produces a maximum inhibition of 55^ at about 3 
X 10"%. This is not shown in the case of the primary phase of 
the contraction. Rather, this is unaffected by V and indeed NP 
produces a sli^t potentiation of the contraction in concentrations 
of around 10"%. This effect is small, however, and the 
variation in these curves is quite large, since these contractions 
in low calcium solutions tend to be variable. The sli^t 
potentiation was seen in all the preparations, however.
The secondary contractions produced by ACh in low calcium are 
inhibited in a similar way to the contractions in normal Krebs,
being markedly affected by both NP and V except that in normal 
Krebs NP is the more effective at producing inhibition, whereas in 
low Ca^ Krebs it is V which is the more effective ( about 95^ 
inhibition being produced by each ). This data is consistent with
the effects of V and NP on the Calcium dose response curve for the
secondary phase of the ACh contraction ( Eig R3-4 ) • It can be
seen from this that at low calcium concentrations V is more 
effective at producing inhibition, but the curves for V and NP 
cross at higher concentrations, so that NP is sli^tly more 
effective at the maximum calcium concentration used. The primary
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phase of the contraction is relatively insensitive to V, but is 
inhibited by KP.
It can be seen that the primary and secondary phases of M  and 
ACh contractions in low calcium Krebs do indeed have dissimilar 
properties compared with each other, and compared to with the 
contractions in normal Krebs.
1.4 Calcium Dose Response Curves.
Calcium dose response curves are shown in Pigs R3-1 to R3-6. 
Primary and secondary contractions are not shown for all three 
agonists. Since Ach and M  only produce bi-phasic contractions and 
a distinct, measurable primary phase at low calcium concentrations 
( below about 5 x ), the variability of the contractions
under these conditions makes it impossible to draw any firm 
conclusions. The doses of the agonists used were the same as those 
used for the antagonist dose response curves, ie KGl = 80mM, NA =
2.5 X 10"%, ACh = 2 X 10“%.
Secondary Phases of Contractions;
The Calcium dose response curves for the secondary phases of 
the contractions induced by the three agonists show marked 
differences with respect to the inhibitory effects of HP and V. 
The contractions produced by ACh are markedly inhibited by both HP 
and V, ( as shown by the shift of the curve to the right and also 
the reduction in the maximum response obtained at higher calcium 
concentrations. ) The extent of the inhibition produced by both is
Fig R3-1 Calcium Dose Respor^e Curves; M
The calcium dose response curve produced by increasing the calcium concentration of the Krebs solutionrWhile repeating a fixed dose of HA (2.5 X 10 %  ), ( triangles, curve labelled"Control" ). Also shown are the effects of a fixed concentration of Verapamil ( 5 x 10“Im , open circles ) and Hitroprusside (2 x 10 'M, filled circles ). Error bars = 1SE. n = 8 for each point.
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Fig R3-2 Oalciim Dose Response Curves; KCl (primary)
As for Fig R3-1, except that the response measured is the primary phase of the contraction induced by KCl ( 80mM ).
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similar ( Eig R3-4 ) • Both antagonists reduce the maximum response
 pof the tissue from ahout 160 Nm"~ to about 110 Nm . This 
reduction is highly significant in both cases^ P < 0.001 for IIP and 
P = 0.001 for V. This effect is not seen with NA, where it appears 
that V has no significant effect and IP only shows marked 
inhibitory effects at calcium concentrations below about 10""%, 
almost 90^ inhibition at a calcium concentration of 2 x 10"%
( Eig R3-1 ) • This inhibition dissappears at higher calcium 
concentrations, so that the maximum response of the tissue is 
unaffected by IIP or V.
The KCl secondary contractions do not reach a maximum in the 
control situation up to a calcium concentration of 6.4mM. Hi^er 
calcium concentrations are not possible because of the pecipitation 
of calcium phosphate. The KGl secondary curve ( Eig R5-5 ) is 
slightly inhibited by RP at low calcium concentrations , at around 
3x10"% RP { 2 X 10"% ) produces an inhibition of 50^? but 
this inhibition is reduced at higher calcium concentrations ( shown 
by the convergence of the curve with the control curve ), 
Substantial inhibition is produced by V, however, and this effect 
is maintained at hi^ calcium levels. The curve for V and the 
control curve are parallel above a calcium concentration of about 
8x10"%.
It should be noted that there is a fundamental difference in 
the shape of the control curves for the agonists. The curves for 
ACh and RA reach a maximum response below the maximum calcium 
concentration used, whereas the KGl curve continues to rise to this
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point, with no sign of a maximum response being reached. The 
possible reasons for this are discussed later.
Primary Phases of Contraction;
ACh and M  only produce bi-phasic contractions below a calcium 
concentration of about 3x10"%. KCl, however, only produces a 
bi-phasic contraction above 2x10"%. The primary response of the 
KCl contraction is much less variable than those of NA and ACh.
Interpretation of the results for the primary responses is 
therefore made more difficult by the variability of the ACh and NA 
contractions. The only clear effect is that the primary response 
of KCl is inhibited by V but not by NP, V producing an inhibition 
of about 30^ at the maximum calcium concentration used ( 6.4mM ). 
( Pig R3“4 ) • This is very similar to the effects of V and NP on 
the-secondary response.
1.5 Dru^ Added During the Plateau Phase of Contraction.
1.5.1 Effect of NP. ( Pig R4-1A,B,C ). - There are marked 
differences in the inhibitory effect produced by NP ( 2 x 10”%  ) 
on the contractions produced by NA,' ACh or KCl. It can be seen 
from Pigs R4-1B and R4-1C that the inhibitory effect is extremely 
rapid in the case of ACh and NA, being greater in the case of ACh 
( about 60^ inhibition ) than for NA ( about 40^ inhibition ). The 
inhibition of the KCl contraction is smaller ( about 15^ ) and not
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as rapid.
Note that the inhibition produced by NP in these cases is 
about the same as would be expected from the antagonist dose 
response curves for each of the agonists, except NA. The 
antagonist dose response curve for NA shows no significant 
inhibition at NP concentrations around 2 x 10"%, but this 
concentration of NP added during the plateau phase produces about 
40g^  inhibition. The two sets of data agree quite well for KCl and 
ACh, however.
1.5*2 Effect of V . ( Eig R4-2A,B,C ). - The differences in the
inhibitory effect of V on each of the three agonists are much less 
pronounced. In all cases the effect of V ( 5 x 10"% ) is much 
slower than NP, ( 2 x 10"% ), which makes interpretation of the 
results much more subjective. On the basis of typical traces it 
appears that the inhibitory effect of V on the three agonists is in 
the order NA > ACh »  KCl, with NA being inhibited the most. It 
should be noted that this is very different from the differential 
effects of verapamil when added prior to the agonists, in which 
case it is the KCl contractions which are inhibited most strongly. 
This difference is probably due to the fact that the effects of V 
on an established contraction are different to those on a 
developing contraction ( see discussion ).
1.6 Addition of Agonists.
If KCl is added to the tissue during the plateau phase of a
Fig R4-1A NP added during the plateau of contraction; NA
The figure shows a_±ypical contraction induced loj NA ( 2.5 X 10 M )* At "NP" a dose of Nitroprusside ( 2 x 10" M ) was added to the hath. The dose was repeated at the second "NP" label ( producing a bath concentration of 4 x 10 M ). The bath was washed out at "¥".
Eig R4-2A V added during the plateau of contraction; NA
The figure shows a typical contraction induced by NA ( 2.5rrX 10"% ). At "V" a dose of Verapamil ( 5 X 10 M ) was added to the bath. At "NP" a dose of Nitroprusside ( 2 x 10" M ) was added, in order to test the responsiveness of the tissue. The bath was washed out at "W".
NP NP W
10 min
V NP W
10 m in
Fig R4-1B HP added during the plateau of contraction; ACh
As for Fig R4=1 A, except that the agonist used was ACh ( 2 X 10”*% ). Note that the calibration is different from Fig R4-1A.
Fig R4-2E V added during the plateau of contraction; ACh
As for Fig R4?2A, except that the agonist used was ACh ( 2 X 10 %  ). Note that the calibration is different from Fig R4-2A.
NP N P W
10 min
V NP W
10 min
Pig R4-1C NP added during the plateau of contraction; KCl
As for Pig R4-1A, except that the agonist used was KCl ( 80mM ). Note that the calibration is different from Pig R4-1A.
Fig R4-2C V added during the plateau of contraction; KCl
As for Pig R4-2A, except that the agonist used was KCl ( SOffiM ). Note that the dose of V was added twice in this case (_rSo the bath concentration at the second "V" =10 M ). This was done because of the apparent lack of effect of V. Note that the calibration is different from Pig R4-2A.
NP NP W 
I I I
10 min
V V NP W
I I  I I
10 min
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pre-existing contraction to ACh or M  it produces inhibition. This 
fast inhibitory effect has been investigated by Gillespie (1972) 
and has been shown to be due to the release of inhibitory 
transmitter by depolarisation of nerve terminals. ( there is also 
a slow inhibitory effect of KCl, which is not relevant in this 
case, -see discussion ) However, if the agonists are added in the 
reverse order, KCl first then ACh or M ,  then the second agonist 
produces an additional contraction. This effect is shown in Eig
R5. This effect is interesting in that it implies a
phrmaco-mechanical coupling of ÏÏA and ACh ( ie. if the membrane is 
maximally depolarised by the presence of 80mM KCl, the subsequent 
addition of HA or ACh has produced an additional contraction 
without additional membrane depolarisation. This effect is 
investigated more fully in the section on electrophysiology. )
It was found that the combined tension produced by the 
addition of ACh to a KCl contraction approximates to the tension 
produced when an ACh contraction was inhibited by the addition of 
KCl ( ie. the final tension is independent of the order of 
addition of the agonists ). This applied also to a certain extent
in the case of HA, althou^ usually the tension produced by HA then
KCl was greater than the that produced by KCl then HA ( see Eig 
R5 ).
This relationship was only true in cases where the inhibitory 
effect of KCl was reasonably long lasting, however. In many cases 
the inhibition was transitory ( lasting 1 to 2 minutes ), which 
made interpretation difficult. It seems likely that these
Eig R5 A Addition of agonists; HA/KCI.
At "KCl" a contraction was induced by 80mM KCl. At "HA" a dose of HA ( 2.5 x lO^^M ) was added. The bath was v^ashed at "W". The second trace shows the effects of the same doses of the agonists added in the reverse order.
Eig R5 B Addition of agonists; ACh/KCl
At "KCl" a contraction was induced by 80mM KCl. At "ACh" a dose of ACh ( 2 x 10 %  ) was added. The bath was washed at "¥". The second trace shows the same doses of the agonists added in the reverse order.
KCl NA W I I I NA KCl WI I I
I9
10 min u
V
KCl ACh W 
I I I
ACh KCl W
19
10 min
u
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differences in the inhibitory effect of KCl may be due to different 
degrees of inhibitory innervation in different muscles, leading to 
either more release of transmitter , or a greater removal of 
transmitter by uptake mechanisms, metabolism, etc.
The additional contractions produced by the agonists added in 
this, way retain their distinct responses to the antagonists. This 
can be see in Pig R6-A. In this case ACh is added to a 
pre-existing KCl contraction. The effect of two different 
concentrations of V on this is shown. It can be seen that the 
initial KCl contraction is almost completely inhibited by V ( 5 x 
10"%. ), whereas the subsequent ACh contraction is unaffected, 
indeed it is actually sli^tly potentiated.
All three agonists can be added in sequence, each eliciting an 
additional contraction. Pig R6-B shows the effect of adding KCl 
then ACh then M  to the preparation. It can be seen that HA can 
produce an additional contraction even in the presence of a 
pre-existing contraction produced by KCl and ACh together.
Fig R6 A Addition of agonists; Effect of Verapamil
The trace shows the response to the two ■ agonists KCl and ACh added as in Fig R5B„( second trace ). At the break Verapamil ( 5 x 10" M ) was added to the bath and equilibrated for 15min. The combination of the agonists was then repeated. At the second break _the dose of Verapamil was increased to 5 x 10" M. ( again equilibrated for 15min. ) The combination of the agonists was then repeated once more. signifies bathwashout in each case.
_ co<
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o
J Z
o<
o
V»t>  o
LO
>  O
LO
Fig R6 B Addition of agonists.
The trace shows that all three agonists can he added sequentially, each producing an additional rise in tension. The doses usedj-were KCl =80n]M, ACh =2 X 10 %  and M  =2.5 x 10"%.
KCl ACh NA
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2.0 CYCLIC NUCLEOTIDE STUDIES
2.1 Justification of Methods.
Tahle R2 gives the results of a typical assay for cAMP. "Count" in 
this case is the number of counts in 10 minutes. Since no 
correction is made for variations in counting efficiency between 
the samples ( ie by external standards ratio etc. ), the data is 
used in the form of counts in 10 minutes directly, rather than 
being converted to DPM. It is unlikely that variations in counting 
efficiency between samples will be large enough to interfere with 
the accuracy of the assay.
TABLE R2.
TUBE C.P.M. C.P.M-BLANK ( Gx ) Co/Cx CONTENTS
1.2 3122 Blank3,4 7262 4140 1 .0 Zero5,5 5446 2324 1.78 1 pmol std.7,8 4950 1838 2.25 2 pmol std.9,10 4226 1104 3.75 4 pmol std.11,12 3706 584 7.08 8 pnol std.13,14 5326 2204 1.87 Unknown
This data gives the calibration curve shown in Pig R7. It was 
found generally that the calibration curves were linear up to 8 
pmol, but at higher levels of cAMP or cGMP the calibration becomes 
less linear. However, most of the samples were below 4pmol, which 
is the most accurate part of the calibration. The assay has a 
co-efficient of variation of less than 11^ over the range 0.2 - 
l6pmol and less than 7^ over the range 0.5 - 4pmol. ( data quoted 
by Amersham ).
Fig R7 Calibration curve for cAMP assay.
The graph shows a typical calibration curve for the cAMP assay. Arrow shows an example of use ( Co/Cx =1 .9, cAMP =1.25pmol ).
8 C o / C x
7
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The calibration curve 'was checked for each assay, with a 
minimum of two standards being determined, unless a new kit was 
being used, some experimental procedure had been changed, or a kit 
had been stored for some time. In these cases the complete curve 
was re-determined.
The main problem with storage of the kits is degredation of 
the binding specificity and affinity of the binding protein ( in 
the case of cAMP ) or of the antiserum ( in the case of cGMP ). 
Generally the binding protein, or antiserum, was split into 
aliquots for storage and only one thawed for use at a time. This 
minimises the number of freeze/thaw cycles that the binding protein 
or antiserum has to undergo. It was found that the binding protein 
or antiserum could be stored for 2 months, when not repeatedly 
thawed and re-frozen, without significant effects being produced on 
the calibration of the assay.
The unknown in this experiment, as read from the calibration 
curve shown, contains 1 .25 pmol ( in the 100ul sample ). The total 
in the original 500ul of buffer is therefore 6.25 pmol.
The calibration curve for the protein assay for this 
particular experiment is shown in Pig R8. The unknown contains 
9.85 mg protein.
The two results are then used to express the final result in 
terms of cAMP/mg protein, in this case 0.63 pmol/mg. The recovery 
in this particular experiment was 55^ for protein and 75^ for o M P .
Fig F8 Calibration Curve tor Protein Assay.
1-0 t ABSORBANCE
0'8 "
0-6 •
0*2
mg. PROTEIN
12
T6 8 10
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The results for the cGMP assays were treated in the same way.
.1
2.2 Results.
The data obtained from the experiments is shown in table R3. This 
shows the cAMP and cGMP levels ( expressed in pmol/mg protein ) for 
the control ( untreated ) muscles, and the changes produced by 
treatment with the three agonists. Also shown are the effects of 
pre-treatment of the muscle with WP ( 1 ) .  These 
experiments, ( shown as NA/NP or KCl/NP ), were performed in the 
same way as the NA and KCl experiments respectively, except that NP 
( 2 X 10-7 ) was added to the bath 15min before the agonist.
The column headed "Protein (mg)" shows the amount of protein 
for each group of pooled muscles used in the experiments. Note 
that the result is for 6 to 8 muscles, so that the protein content 
of one muscle is about 1 to 1 . 5mg, The wet weight of one muscle is 
of the order 5 to 7mg. Note that the protein result obtained for 
experiment NA 1 is low compared to the rest. This is because the 
tube was dropped in this experiment, leading to some loss of the 
extract. The results for cAMP and cGMP are very similar to those 
for the other NA experiments, so the result is included here. It 
was assumed that the extract was homogeneous at this stage so the 
loss did not affect the levels of cyclic nucleotides expressed as 
pmol/mg protein.
The column headed "P value" shows the probability level 
associated with each result, compared to the control value. This 
was calculated using Student's paired T test. The P value for the 
NA/NP group compared to the NA group is < 0.001. The P value for
Table R3 Qyclic Nucleotide Assay Results.
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the KCl/NP experiment compared to the KCl group is < 0.01.
The results show that the level of cAMP in this tissue is low 
and variable in unstimulated muscles. ( 0.9 pmol/mg ). It appears 
to be changed little by the action of the agonists, except possibly 
by NA, which causes a slight rise, ( from 0.9 to 1 ,39 pmol/mg. 
0.1 < P < 0,2 ). All three agonists cause a pronounced fall in 
cGMP levels, however. The significance levels for these changes 
are low, but this is probably due to the small number of data in 
each group.
Pre-treatment with NP prevents the fall in cGMP levels caused 
by the agonists, rather it is replaced by a definite rise ( from 
0,37 to 0.76 pmol/mg ) This effect is shown when either NA or KCl 
are used as the agonist, NP does not appear to affect the cAMP 
levels when the muscle is stimulated with NA or KCl, althou^ the 
slight rise in cAMP levels caused by NA is not seen in this case. 
This may be a secondary effect due to the fact that cGMP does not 
fall- see discussion.
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3.0 ELEGTROPHYSIQLOGY
3.1 General
Only in exceptional circumstances could a cell be recorded from 
continuosly, using the intracellular microelectrodes obtained, for 
more than 20 seconds or so. Usually the potential was seen to 
drift after this time as the electrode came out of the cell. In 
most cases any attempt to stimulate the muscle while a cell was 
impaled resulted in the electrode being dislodged. Ths was in 
spite of the fact that the muscle was under fairly hi^ resting 
tension and also that the cells were usually impaled near to an 
imobilised area of the muscle ( ie. near to one of the pins ). In 
some instances, however, it was possible to record from a cell 
while the muscle was stimulated in some way, possibly because the 
cells in these cases were larger than average. Examples of these 
traces are shown in Pigs R9-1 to R9-5»
3.2 Results
The results of the "population" measurements of membrane potential 
are shown in tables R4 and R5.
Table R4 shows the membrane potential of a sample population 
of cells for control ( unstimulated ) muscles and the membrane 
potential of a sample population of cells after the muscle had been 
stimulated by each of the three agonists, NA, ACh and KCl. For 
each of these situations the number of cells penetrated (n), the
TABLE R4
Electrophysiology results; Effect of NP.
TABLE R5
Electrophysiology results; Effect of V.
NO ANTAGONIST NP ( 2 X 10' )
n Mean SE n Mean SE ^ P value
Control 26 -55.2 1.22 20 -58.0 1.16 0.1
M 22 -30.8 1 .26 24 -35.1 0.82 > 0.001
ACh 21 -27.3 0.87 22 -33.0 ' 0.76 < 0.001
KCl 30 — 19*8 0.26 18 -20.2 0.35 > 0.2
NO ANTAGONIST V ( 5 X 10"^M )
n Mean SE n Mean SE P value
Control 26 -55.2 1.22 21 -51.8 1.26 > 0.05
NA 22 -30.8 1.26 19 -34.2 1.15 > 0.05
ACh 21 -27.3 0.87 22 -31.6 0.86 =0.001
KCl 30 -19.8 0.26 17 -19.1 0.42 > 0.01
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mean of the membrane potentials measured (Mean), and the standard 
error of this mean (S.E. ), are shown. The second column of
results, headed NP ( 2 x 10“^M ), gives the results of the same 
measurements in the presence of NP. The final column shows the
significance level of the result in the presence of NP as compared
to that in the "no antagonist" situation.
Table R5 shows the same results as table R4 for the "no
antagonist" situation in the first column, but these are compared 
to results obtained in the presence of V ( 5 x 10“'^ M ), shown in 
the second column. Again, the P value is that compared to the "no 
antagonist" situation.
It can be seen that the resting membrane potential measured in 
the control situation was ~55.2mV. This is not significantly- 
changed by the presence of NP or V. A maximal dose of NA produces 
a depolarisation of the membrane to a potential of -30.8 mV. The 
depolarisation produced in the presence of NP is sligRly less, to a 
potential of -35.1mV. The difference between these results is 
significant, ( 0.01 > P > 0.001 ). The depolarisation produced by 
NA in the presence of V is again slightly less than that produced 
in the "no antagonist" si-fcuation, although in this case the 
difference is less significant, ( P > 0.05 )•
A maximal dose of ACh produces a depolarisation of the 
membrane to -27.3mV in the "no antagonist" situation. Both NP and 
V reduce this deplolarisation by a significant amount. In the 
presence of NP the depolarisation is to -33.0 mV, ( p < 0.001 ).
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In the presence of V the depolarisation is to -31 *6 mV, ( P < 
0.001 ).
KCl ( 8QmM ) produced a membrane depolarisation to a potential 
of -19*8 mV. This was not significantly affected by NP or V.
To Summarise;
NA produces a depolarisation to about -31mV, This
depolarisation is sli^tly reduced in the presence of NP ( sli^tly 
significant ) and also slightly reduced in the presence of V ( not 
significant ).
ACh produces a depolarisation to about -27mV. This
depolarisation is reduced in the presence of NP and V ( both highly 
significant ).
KCl produces a depolarisation to about -20 mV. This
depolarisation is not affected by NP or V.
Note that althou^ KCl produces the greatest depolarisation, 
it produces the smallest increase in tension in the mechanical 
experiments.
Fig R9-1
Trace showing a penetration of a cell which meets the criteria stated in the text. Upper trace shows potential recording, lower trace shows tension ( not operative in this case ). At "A" a cell was penetrated, recording a membrane potential of approximately -52mV. At "B" the electrode potential drifts, indicating that the electrode is leaving the cell.
r + 5 0 mV 10 secI----1
0
”50 mV
7
Fig R9-2 Effect of NA.
Upper trace shows a resting membrane potential of approximately -55mV. At "A" a maximal dose of NA was added to the bath. This causes a rise in tension from 5g to about 15g and a depolarisation to about -25mV. The temporal difference in the traces is due to the fact that the agonist is added to one end of the bath and distributed by the perfusion and by diffusion.
Fig R9-3 Effect of ACh.
Upper trace shows a resting membrane potential of approximately -6QmV. At "A" a maximal dose of ACh was added to the bath. This causes a rise in tension from 5g to about 10g and a depolarisation to approximately -20mV.
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mV ' -30
' 10
A
A
mV
0
-30
-60
r
10sec
10
0
A
A
Fig R9-4 Membrane Oscillations.
At "A" a maximal dose of ACh was added to the hath. This causes the rise in tension seen on the lower trace, hut dislodges the electrode from the cell at "B" ( previously recording a restingpotential of approximately -60mV ). At "C" another cell is %^netrated, giving a memhrane potential of approximately 20mV, which slowly increases to approximately -3CtaiV. The memhrane potential shows oscillations of about 2mV amplitude at a rate of 0.3Hz. The electrode leaves the cell at "D".
Fig R9-9 Addition of Agonists.
Upper trace shows the memhrane potential recorded from a cell in 80mM KCl solution. Lower trace shows the tension recorded. At "A" a maximal dose of NA was added to the hath. This produces a rise in tension hut only a small additional depolarisation. The electrode was dislodged at "B". "Cal" indicates a 10mV signal from the pre­amplifier.
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SECTION 1 ; ACTIVATION BY THE THREE AGONISTS.
1.0 Introduction; |
i
Pig D1 shows the typical contraction produced by a maximal dose of 
each of the three agonists. It can he seen that ACh and NA both 
produce a very similar type of contraction, with a rapid rise in 
tension to about 75^ of the final tension, then a slow further 
increase in tension to the maximum finally attained, over a period 
of some 15 to 20 minutes. A maximal dose of KCl, however, produces 
a contraction showing a bi- phasic form.
Evidence presented later ( section 2 ) indicates that KCl
contractions depend to a large extent upon an influx of
extracellular calcium. The properties of the two phases were found
to be very similar with respect to the effects of antagonists 
( especially Verapmil ). This indicates that the two phases of KCl 
contractions are probably not due to different activation pathways, 
rather, the bi- phasic form of the contraction appears to be due to 
calcium sequestration or pumping mechanisms. If the initial influx 
of calcium causes a rise in intracellular levels of calcium lAich 
is then taken up into intracellular stores, this could cause the 
transient primary phase seen. If these stores subsequently become 
saturated, the level of calcium would once again rise. In this way 
the bi- phasic form of the contraction can be accounted for by 
calcium eqilibration within the cell. It is possible that the 
calcium induced release of calcium described by Cheng ( 1976 ) 
plays a part in this process. If this release of calcium is
Fig D1 T^ypical Contractions induced by each Agonist.
Contractions induced by 80mM KCl, 2 x 10"^M ACh and 2.5 X M.
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somewhat delayed, this could also contibute to the production of a 
hi- phasic type of contraction.
It appears that M  and ACh do not produce this type of bi- 
phasic contraction because they use different activation pathways, 
M  and ACh induced contractions do not depend to any great extent 
upon the influx of extracellular calcium ( section 2 ), but rather 
they produce an amplification of a small, initial calcium signal. 
This would mean that the calcium equilibration processes during 
contraction are different.
The other main difference in the contractions is that the 
maxima are very different. This is illustrated better by the 
agonist dose response curves shown in Pig R1 . These different 
maxima may be due to several factors.
1 ) It is accepted that the contraction of smooth muscle 
is due to a rise in the intracellular concentration of calcium, 
in the same way as skeletal muscle ( Sandow 1965 ,
Gordon 1978 ).
NA and ACh may produce a greater permeability change in the 
membrane, so allowing a greater influx of calcium, hence a greater 
rise in cytoplasmic calcium levels ( as will be seen, this is 
unlikely ).
2) RA ( and to a lesser extent, ACh ) may cause the release 
of intracellular stores of calcium, while KCl does not. If RA is 
more effective at producing this effect, it would produce a greater
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rise in cytoplasmic calcium levels, without a greater influx.
Such a release of intracellular calcium by RA activation has been 
proposed in many smooth muscles. ( Collins, Sutter and Teiser 1972, 
Deth and Van Breemen 1974, Godfraind 1976, Keating 1972 ).
3) It is possible that M  and ACh are capable of 
indirectly increasing the response of the contractile apparatus 
to a given calcium concentration. In this way it, would be possible 
for them to produce a greater response although the rise in 
intracellular calcium levels would not be as great as with 
KCl activation.
These possibilities are disscussed in more detail in the following 
sections.
Another point of interest in the agonist dose response curves 
is that while M  and ACh produce a graded response from very low 
doses, KCl shows a distinct mechanical threshold, at around 20mM. 
Below this concentration no consistent response is produced, while 
above it the developed tension rises rapidly with increasing KCl 
concentration.
This type of effect has been investigated by Byson and Huddart 
(1973) in the rat vas deferens and ileum, where they found that KCl 
produced no appreciable mechanical threshold. This difference may 
be due to the fact that rat vas deferens and ileum are 
spontaneously active and produce action potentials ( APs ). Since 
KCl, at low concentrations, was found to increase spike frequency.
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( although at hi^er concentrations it will suppress spike
generation and produce a depolarisation of the membrane, Syson and 
Huddart 1976 ), this may be the way in which it increases tension 
in this preparation. A gradual increase in spike frequency would 
be expected to produce a graded increase in tension, since one of 
the main current carriers during the AP is calcium ( Kuriyama 
1970 ).
The rat anococcygeus does not produce APs ( this study, also 
Creed, Gillespie and Muir 1975 ), so such a mechanism is not 
possible. The mechanical threshold seen in this muscle is a
reflection of the fact that the depolarisation caused by KCl opens 
voltage dependent channels at some threshold value, this threshold 
being at a KCl concentration of about 20mM. This gives the effect 
of a sudden "switch on" of the activation process with increasing 
KCl concentrations, at the point at which membrane depolarisation 
is sufficient to open voltage dependent channels ( VDCs ), so
allowing the influx of extracellular calcium.
The fact that RA and ACh do not produce such a mechanical 
threshold indicates that the activation processes used by them are 
different. This would support the idea that membrane 
depolarisation leading to the opening of voltage dependent channels 
is not the most important event in the activation by RA and ACh. 
It may be that they produce opening of receptor operated channels 
( ROCs ) in the membrane, and this could produce the finely graded 
responses seen. However, the electrophysiology section of this 
study shows that a dose of RA which produces a depolarisation of
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the membrane to -30.8mV produces a greater response than a dose of
ACh which depolarises the membrane to ~27.4mV ( a greater
depolarisation ). 8QmM KCl produced the greatest depolarisation 
( to -19*8mV ), but the least rise in tension. This indicates that 
RA especially, but also ACh, must produce some "amplification 
stage" in the activation process. If this process can respond in a 
graded manner, this would also give the graded responses seen.
The following sections consider the ways in which the agonists 
could produce different maxima, and the evidence that membrane 
depolarisation per se is not the fundamental factor in determining 
the response of the muscle. The evidence indicates that important
"second messenger" changes ocurr, especially in the level of cyclic
nucleotides, and these may control the contractility of the muscle.
2.0 Electrophysiology
The resting membrane potential of a population of cells in the rat 
anococcygeus muscle was -55.2mV ( S.E. 1.22 ), measured in control 
conditions ( see table R4 )■ Creed ( 1974 ) quotes a value for 
this of -62.1mV ( S.D 7«8 ) , However, Creed, Gillespie and Muir 
( 1975 ) reported a sli^t change in the resting membrane potential 
when the resting tension was changed. At a resting tension of < 
0.75g they recorded a potential of -58.1mV ( 8.D. 5mV ). When the 
muscle was stretched to the point where stimulation no longer 
produced any movement, the potential was -61.5mV (S.D. 8.1 )
Althou^ this  ^difference was not statistically significant, the 
results do indicate that a slightly different resting membrane 
potential can be recorded depending upon the experimental
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conditions. On this basis the value of -55»2inV ( S.E. 1.22 )
recorded in this study indicates that the recording system used 
gave results which were comparable to those obtained by other 
workers.
NA ( 2 X 10"% ) produced a membrane depolarisation to a
value of -30.8mV. This concentration of NA produced a rise in
—2tension of about 250Nm . This value agrees well with other
published results ( Creed et al 1975 )• The effects of NA ( and 
other agonists ) are different in the rat anococcygeus muscle to 
those in many smooth muscles, since the anococcygeus muscle does 
not produce action potentials under normal circumstances ( Creed 
1975 )• The rat anococcygeus is also reported to give no resonse 
to B adrenergic stimulation , so the response seen to NA is an 
response.
Alpha adrenergic stimulation is generally accompanied , by 
depolarisation, and an increase in the frequency of APs ( in those 
muscles producing APs ) ( Bolton 1979 ), although a number of
papers have been published which report that activation can produce 
a contraction with little or no change in the membrane potential in 
a number of smooth muscles ( Casteels et al 1977, Droogaans and 
Casteels 1977, Su, Bevan and Ursillo 1964, Droogmans et al 1977 )• 
The effect of receptor stimulation generally appears to be an 
increase in membrane conductance, which implies that the receptors 
are capable of opening ion channels in the membrane ( Receptor 
Operated Channels, ROCs ). The basis of the permeability change 
which accompanies o< receptor activation is thou^t to be an
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increase in the permeability to sodium, chloride and possibly 
potassium ( Casteels et al 1977, Droogmans et al 1977 )» The role 
of calcium permeability changes is uncertain. Some authors have 
suggested that there is an increase in calcium influx ( or efflux ) 
during activation, ( Godfraind 1976, Wahlstrom 1975, Turlapaty, 
Hester and Carrier 1976 ). althou^ others have, found no change 
( Keating 1972 ) or a decrease ( Hudgins and Weiss 1968, Seidel and 
Bohr 1971 )• It should be-noted, however, that in many instances 
calcium influx ( or even membrane depolarisation ) appears to be 
unecessary for the action of NA. The release of calcium from 
intracellular stores is often sufficient to produce a contraction. 
In this connection, receptor activation has been reported to
reduce calcium binding to aortic microsomes ( Baudouin-Legros and 
Meyer 1975 )•
ACh ( 2 X 10"% ) produced a depolarisation of the membrane 
in this study to a value of -27-4mV ( S.E. 0.87 )• This
pconcentration of ACh produced a rise in tension of about 165Nm . 
Like NA, ACh produces a variety of effects on smooth muscles. In 
all smooth muscles the effect of ACh is mediated via muscarinic 
receptors. In those smooth muscles in which it produces a 
contraction, ACh also produces depolarisation. It is interesting 
to note that pronounced inter- species differences occur. In the 
rat anococcygeus, ACh produces contraction and depolarisation, 
( this study ), whereas in the rabbit and the cat, the anococcygeus 
muscle is relaxed by ACh ( Gillespie and McGrath 1974, Creed, 
Gillespie and McCaffeiy 1977 )•
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Muscarinic receptor activation generally is thought to 
increase membrane permeability to sodium and potassium, ( and 
possibly chloride ), by opening ROCs ( Bolton 1972 ). Some workers 
have found an increase in calcium influx upon muscarinic receptor 
stimulation ( Banergee and Lewis 1965, Lammel 1977 ) whereas others 
have found no increase ( Hodgson and Daniel 1975, Van Breemen and 
Daniel 1966 ). Calcium permeability changes induced by various 
agonists in many smooth muscles have been measured using calcium 
isotope efflux techniques ( Saad and Huddart 1981 ). The results 
of this type of experiment indicate that smooth muscles vary widely 
in their dependence upon calcium influx for activation, and this 
appears to correllate well with the developement of intracellular 
stores. It would appear that, as for cxL receptors, calcium 
permeability changes are not the most important ones induced by 
muscarinic receptor stimulation and thus calcium influx is not of 
primary importance in the production of a response.
KCl ( 8QmM ) produced a depolarisation of the membrane in this
study to a value of ~19-8mV ( S.E. 0.26 ). This concentration of
— PKCl produced a rise in tension of about 90Nm . The typical bi- 
phasic contraction induced by KCl in the rat anococcygeus is 
similar to that reported in other smooth muscles ( Gabella 1978, 
Syson and Huddart 1975 ), especially in those types which produce 
APs. In these the initial fast rise in tension appears to be 
associated ifith an initial burst of APs. In muscles which do not 
produce APs, KCl usually produces a slow rise in tension which 
gradually approaches a maximum. The rat anococcygeus is unusual in 
this respect, in that although it does not generate action
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potentials the initial rise in tension is very rapid. This is not 
due to the action of NA released from nerve terminals, since in all 
experiments with KCl phentolamine is included in the Krebs 
solution.
Hi^ K"^  solutions exert their effect on membrane potential 
primarily by altering the potassium gradient across the membrane. 
Resting membrane potential is largely determined in smooth muscles 
by the potassium equilibrium potential ( Casteels et al 1977,
Holman 1958, Kuriyama 1963 ), but sodium and chloride also have an 
appreciable effect, so that changing the ionic gradient for 
potassium will change the membrane potential. It is thou^t that 
the change in membrane potential opens voltage dependent ion 
channels ( VDCs ) which permit the entry of calcium down its 
electrochemical gradient and so initiate contraction. Internal 
K^ concentrations have been shown to be of the order of 150mM in 
most smooth muscles ( Scheid and Eay 1980 ). If this is true of
the rat anococcygeus muscle, then the potassium equilibrium
potential in normal Krebs will be approximately -87mV. The resting 
membrane potential was measured as -55-2 mV, indicating that other 
ions besides K"** are involved in the maintainence of the resting 
membrane potential. In 8QmM KCl the potassium equilibrium
potential will be about -15*8mV. However, it has been shown that 
smooth muscles deviate from the expected membrane potential in hi^ 
K^ solutions to various degrees. Teania coli cells produce a 
relationship between external and membrane potential which 
agrees fairly well with the predicted relationship, whereas 
vascular smooth muscle exibits little change in membrane potential
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with variations in external concentration. The deviation from 
the predicted relationship is no doubt due to rectification by the 
membrane due to the opening of various voltage dependent channels. 
Also, electrogenic pumping is increased by hi^ external K^ , 
which leads to the intracellular accumulation of K^.
Although this deviation from the predicted relationship means 
that it is impossible to calculate in advance what the membrane
potential will be for a given concentration, the value found
in this study, (-19.8mV for 80 mM KCl), would indicate that the 
deviation from the theoretical value in the case of the rat 
anococcygeus is not as great as found in many other smooth muscles.
The results obtained for the three agonists indicate that 
there is no simple relationship between the membrane potential 
produced by an agonist, and the ability of that agonist to induce a 
contraction. This is due to the different activation processes
used by each of the agonists to couple membrane permeability
changes to contraction of the muscle ( and also because the inital 
permeability changes are different ),
More evidence for the existence of these activation processes 
used by the agonists to regulate contractility can be obtained from 
the calcium dose response curves.
5*0 Calcium Dose Response Curves; Control Curves.
Pig D2 shows the control curves for each agonist plotted on the 
same scale. The curves provide useful information about the
Pig D2 Control Calcium Dose Response Curves
Control calcium dose response curves for each agonist taken from the Calcium dose response section, plotted on the same scale.
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activation processes used by the agonists. Although the 
depolarisation produced hy increasing concentrations of KCl is 
often not simply related to the KCl concentration, ( see above ), 
this problem is not too crucial in these experiments, since the 
concentration of KCl used 'was constant at 8QmM. It can he assumed 
that the permeability change produced is therefore constant. If 
this is so, then the linear relationship seen when tension is 
plotted against log [Ca^] for KCl induced contractions merely 
reflects the dependence of the contraction on calcium influx, since 
increasing the extracellular calcium concentration will increase 
the electrochemical gradient which drives calcium influx. This 
linear relationship is produced since the contractile proteins 
themselves respond to the log of the intracellular calcium 
concentration in this way ( Gordon 1978, Endo, Kitazawa, Yagi, lino 
and Yakuta 1977 ). This line of reasoning can be represented thus;
For the contractile proteins themselves;
Response «x log [Ca^]i (intracellular calcium conc.)
If we assume that the internal calcium concentration is related 
directly to the calcium influx, then;
Response cUi log ( Influx )
If we add a proportionality constant, K;
Response = K log ( Influx )
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Now
Influx = Calcium Gradient x Membrane permeability
So;
Response = K Log ( Gradient x Permeability )
Since the permeability of the membrane is assumed to be constant, 
( due to the constant concentration of KCl used ), this equation 
describes the relationship between response and log [Ca"^] shown 
in fig D2 very well.
It can be seen that ACh and NA also produce this linear 
relationship between calcium concentrations of 10”^ to 10"%.
The slope of the lines is much greater, however. It is apparent 
from the equation derived above that a change in the permeability 
of the membrane will result in a shift in the line parallel to the 
log [Ca^] axis, but that the slope will remain constant. A 
change in the proportionality constant, K, however, will result in 
a change in the slope of the line. This proportionality constant 
can be thought of as an index of the amplification processes which 
are used by NA and ACh to increase the response to a given calcium 
signal ( ie. an index of the pharmaco-mechanical coupling ). The 
data indicate, therefore, that NA and ACh produce a greater 
contraction by an amplification of the initial calcium signal, 
rather than by an increased permeability.
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As stated earlier, in the rat anococcygeus muscle NA induced 
contractions are less affected by removal of the extracellular 
calcium ( or by Verapamil ) than KCl induced contractions. This 
indicates that NA causes contraction by release of intracellular 
stores of calcium, althou^ it may be that the amplification of the 
calcium signal produced by NA is so powerful that a small 
contraction can be produced as a result of the very small calcium 
influx under these conditions. Results quoted by van Breemen ( Van 
Breemen, Farinas, Casteels, Gerba, Wuytack and Deth 1973 ) indicate 
that, at least in the rabbit aorta, NA stimulation produces less 
calcium influx than does KCl depolarisation. The evidence supports 
the view, therefore, that NA and ACh do not produce a greater 
contraction by a greater change in membrane permeability, hence a 
greater calcium influx. rather, they have a greater secondary 
pharmaco-mechanical coupling effect, which can act to amplify the 
response to what may be a smaller initial calcium signal.
3.1 Maximum response of NA and ACh;
The calcium dose response curve for KCl induced contractions is 
still rising at the hipest calcium concentration used, ( 6.4mM ), 
whereas the curves for NA and ACh induced contractions reach a 
maximum at about 2mM. Initially it was thou^t that this 'leveling 
off mi^t be due to calcium phosphate precipitation, leading to a 
maximum attainable ionised calcium concentration. This is unlikely 
to be the cause, however, since the KCl induced contractions are 
still rising. The possible explanations of this effect on NA and 
ACh induced contractions could be;
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1 ) That hi^ concentrations of calcium are producing a 
membrane stabilising effect, influencing the permeability changes 
produced by NA and ACh. This type of membrane stabilising effect 
of calcium has been shown in other preparations ( Collins, Sutter 
and Teiser 1972 and Prankenhauser and Hodgkin 1957 ) However, a 
membrane stabilising effect of hi^ calcium solutions would be 
expected to affect KCl induced contractions also, if this effect 
was on membrane permeability. The other possibility is that 
calcium bound to the membrane can regulate the release of the 
stores of calcium associated with the inner surface of the membrane 
or the receptors themselves. The existence of such regulatory 
calcium binding has been suggested by Weiss (1977).
2) Hi^ calcium solutions may interfere with the binding of 
the agonist to the receptor. Calcium has been shown to be 
necessary for the binding of NA to alpha receptors ( Bulbring and 
Tomita 1977 ), so it may be possible that hi^ calcium solutions 
can interfere with this process in some way. No similar 
information exists for muscarinic receptors.
It is possible that the amplification stage in the activation 
processes used by NA and ACh becomes saturated in its ability to 
amplify the small initial calcium signal. This would lead to a 
maximum contraction being reached, with these maximum contractions, 
however, still greater than the KCl induced contractions. If the 
amplification process is different ( and/or more powerful ) for NA, 
this concept would also explain the greater response possible to NA 
before the process becomes saturated. This more powerful
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amplification stage produced by NA activation ( and to a lesser 
extent ACh ) as compared to KCl activation is also illustrated by 
the experiments in which NA and/or ACh were added to a pre­
existing KCl contraction.
4 • 0 Addit i on of agonists.
The fact that agonists can produce additional contractions in KCl 
depolarised muscle has been reported in various preparations 
( Peiper, Griebel and Wende 1971 ). NA and ACh can induce 
additional contractions in the rat anococcygeus muscle depolarised 
by 8QmM KCl. It was shown earlier that this concentration of KCl 
depolarises the membrane to about -2QmV. It is reasonable to 
suppose that this is not changed by the subsequent addition of NA 
or ACh. ( see electrophysiology ). The fact that this addition of 
NA or ACh can produce an additional contraction must therefore be 
taken as an effect of these agonists on events subsequent to 
membrane depolarisation. It would appear, therefore, that the data 
supports the hypothesis that NA and ACh produce some additional 
amplification stage, which acts on events subsequent to membrane 
depolar isati on.
The observation that the three agonists can be added in the 
order KCl/ACh/NA, each producing an additional contraction, and the 
observation that the combination of KCl/ACh produces a lower total 
response than the combination of KCl/NA, indicates that ACh 
produces a less powerfull "amplification" than NA. This fits the 
idea that NA and ACh use subtly different second messenger 
"amplification" systems.
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That agonists added together in this way retain their 
characteristic sensitivities to antagonists has been reported by 
Peiper, Greible and Wende ( 1971 ). They found similar results to 
those quoted in this study for the rat anococygeus in the rat 
aorta, ie that V inhibited the inital KCl contraction, but did not 
substantially affect the subsequent NA contraction.
The data in the previous sections supports the view that NA 
and ACh do not produce a greater contractile response by membrane 
effects ( eg by producing greater calcium influx ), but rather by 
some amplification step in the activation process which is involved 
in the control of contractility. The main candidates proposed for 
this role in the control of contraction are the cyclic nucleotides, 
cyclic AMP and cyclic GMP.
5.0 Cylic Nucleotide Studies;
Cyclic nucleotide changes have been implicated in the changes in 
contractility of various smooth muscle preparations. The relaxing 
effect of p adrenergic stimulation has been linked to a rise in 
intracellular cAMP levels ( Andersson 1972,1973, Murad and Kimura 
1974, Ohkubo, Takayanagi and Tagagi 1976 ). However, the changes 
in cyclic nucleotide levels which accompany the excitatory effects 
of drugs are much more variable ( Bar 1974 ) » In some muscle 
preparations an increase in cGMP has been associated with 
contraction. Thus, it was found by lee et al ( 1972 ) that 
muscarinic stimulation in various tissues resulted in a rise in 
cGMP and a sli^t fall, or no change, in cAMP. Similar results 
have been found by Schultz Hardman, Hurwitz and Sutherland
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( 1973 ), in the ductus deferens and small intestine. Subsequently 
this work was confirmed ( Schultz, Schultz and Hardman 1975, 
Schultz et al, 1973 ), but some doubt was cast upon the role of 
c(MP by the finding that changes in cGMP did not correllate well 
with the time course of the contraction. Diamond and Holmes 
( 1975 ) showed also that KCl depolarisation caused a fall, rather 
than a rise in cGMP in the rat nyometrium associated with
contraction, and that the relaxant effects of papaverine and
nitroglycerine did not correllate well with their ability to
produce changes in cGMP levels.
Althou^ it seems, therefore, that the role of either cGMP or
cAMP alone is not well defined, the possibility exists that the two
act in an antagonistic way to regulate cell function. Thus an 
increase in cGMP may be linked to contraction, while an increase in 
cAMP is linked to relaxation. This so called Ying/Yang hypothesis 
was first proposed by Goldberg ( Goldberg et al 1975 ). This idea 
has subsequently been refined so that the proposed controling 
mechanism is now thou^t to be the ratio of cAMP to cGMP.
( Dunham, Haddox and Goldberg 1974, Dee, Kuo and Greengard, 1972 )
The Hat Anococcygeus;
It can be seen from table R3 that HA stimulation ' of the 
muscles caused a slight rise in cAMP levels, whereas ACh and KCl 
did not. This may be due to the existence of a small number of B
receptors in this tissue, althou^ experiments have shown that B
agonists have little or no pharmacological effect in the rat
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anococcygeus ( this study, unpublished results ). It is widely 
accepted that in general B receptor stimulation causes a rise in 
cAMP levels in many tissues ( Scheid, Honeyman and Eay 1979 ) and 
it is possible that the sli^t rise in cAMP observed could be due 
to a small number of receptors, which do not contribute to the 
contractile responses of the tissue under normal circumstances.
More pronounced changes in the levels of cGMP are produced by 
the agonists. All three cause a fall in cGMP from the control, 
value of 0.337 pmol/mg protein. The greatest fall is. caused by 
ACh, to 0.109 pmol/mg. Both NA and KCl produce a fall to around 
0.16 pmol/mg. This result is the opposite to that most often 
quoted, ie. that agents which cause contraction generally raise 
cGMP. However, one or two cases have been quoted where contraction 
is accompanied by a fall in cGMP levels ( Diamond and Holmes 
1975 ). At first it seems difficult to reconcile these results 
with any proposed role of cAMP or cGMP in the contraction of the 
rat anococcygeus muscle, since the levels of the nucleotides do not 
appear to correllate with the tension produced by each agonist.
However, a good correllation is obtained between the ratio of 
the levels of cAMP/cGMP produced by activation by each of the 
agonists, and the maximum tension produced by those agonists. It 
should be noted that the maximum tension values used here are not 
those produced by the muscles which were actually assayed for cAMP 
and cGMP. Although desirable, this was not possible since the 
muscles were freeze clamped at the time of maximum tension. This 
precludes the weiring step used in the mechanical experiments to
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convert the tension to Nm"^. Instead the maximum tension 
produced by each agonist in the mechanical experiments was used. 
Since the muscles used for the assay were freeze clamped at the 
point of maximum tension ( induced by the same concentration of the 
agonists used in the mechanical experiments ), it was felt that any 
errors would not be great enou^ to affect the conclusion.
Table R6 shows the max. tension and the cyclic nucleotide 
ratio produced by each agonist, compared to the control situation.
Table R6:
AGONIST Max TENSION [ Nm“^ SE ] RATIOcAMP/cGMP MEANRATIO
NA 247 13 8.4,8.5,7.8 8.35
ACh 170 9 6.8,7.0 6.9
KCl 99 5 4*5,4.6,4.7 4.6
CONT 15 2.4,2.1,3.5 2.6
Pig D3 shows the result of plotting the tension induced by 
each agonist against the ratio of the levels of cAMP/cGMP produced 
by that agonist. It can be seen that a good strai^t line can be 
drawn throu^ the points for the three agonists and the points for 
the control muscles, ( set up under 1g resting tension, approx 15
_pHm ). Regression analysis of the data points gives an equation 
for this line of y=-86 + 39.3x, with a correllation coefficient of 
0.9825.
This good correllation between the tension produced and the
Fig D3 Ratio cAIW/oGW versus Tension.
The graph shows a plot of the ratio cAMP/cG-MP produced hy a maxmal dose of each agonist against the tension produced by „that dose. Doses are; KCl 80mM, ACh 2 x 10“%  and NA 2.5 x 10“%. Ratios are plotted as points, each point being a result from Table R2. Tension is taken from the mechanical studies section and is plotted as mean tension, error bar is 1SE. n=8 for each agonist. The dotted line is that ^nerated T:%r regression analysis of the points. The equation for this line is j- -86 + 39.3x. The correllation coefficient is 0.9825.
The point marked NA/NP is that produced by pre-treatment with NP ( 2 x 10 M ) prior to NA addition. The point marked KCl/NP is that produced by pre-treatment with the same concentration of NP prior to the addition of KCl.
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ratio of cAMP/cGMP produced by each agonist would seem to be good 
evidence in favour of the hypothesis that the ratio of the two 
cyclic nucleotides acts in some way to regulate the contractility 
of the muscle.
Exogenous cAMP and c(MP analogs;
If this is indeed the case, then raising the level of one or 
other of the nucleotides by some means ( or using analogous 
compounds ) should cause differential changes in the contractility 
of the muscles, in accordance with the scheme above. Di- butryl 
cAMP, an analogue of cAMP, has been shown to relax vascular smooth 
muscle ( Webb and Bohr 1981 ), guinea pig trachea ( Moore, lorio 
and McManus, 1968 ) and rat ileum and uterus ( Overweg and Schiff 
1978 ). However, some authors have reported that di- butyryl cAMP 
causes activation of rat vas deferens and ileum ( Saad and Huddart
1980 ), and they conclude that cAMP is not important in the 
relaxation mechanism in these two muscles.
8- bromo cGMP is an analogue of cGMP, which can be used in the 
same way. 8- bromo cGMP and di- butyryl cAMP have been used in the 
study of the control of cardiac contractility and have been shown 
to exert antagonistic effects in this tissue ( Sing and Elitney
1981 ). Thus if the ratio of cAMP/cGMP is important in regulating 
the contractility of the rat anococcygeus muscle, then exogenous 
di- butryl cAMP should cause a contraction, ( or enhance a 
contraction caused in some other way ) and exogenous 8- bromo cGMP 
should cause a relaxation. ( or inhibit a contraction caused in
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some other way ). Pig D4 shows the effect of exogenous 8- hromo 
cGMP ( 5 X 10"% ) on the muscles when the muscle Is prevously 
contracted hy either NA or KCl. ( maximal doses ). 8- hromo cGMP
caused a relaxation in both cases. This relaxation is greater in 
the case of M ,  which may be an indication of the greater reliance 
of NA on changes in cyclic nucleotides in the production of a 
contraction. The effects of exogenous di- butyryl cAMP are shown
in Pig D5 * It would be expected that this would cause a
contraction. However, it can be seen that, on a preparation 
contracted with KCl, di- butyryl cAMP ( 5 x 10"% ) causes a 
sli^t, transient relaxation. This may be due to the other efects 
of cAMP and its analogues in the cell (eg, on phosphorylase 
kinase, etc. ). On muscles contracted with NA, however, di- 
butyryl cAMP caused a pronounced, sustained relaxation. This may 
be because the muscle is already maximally contracted by NA, so 
futher contraction is not possible. The relaxant effect may be due 
to the effefcts of cAMP analogues on cGMP metabolism (eg. it has 
ben shown that cAMP can inhibit the hydrolysis of cGMP by 
phosphodiesterase ( Brostrom and Wolff, 1976 ). Also, in tracheal 
smooth muscle, a protein has been demonstrated which will bind 
cAMP, and which shows the same "t^e of cross reactivity to cAMP and 
cGMP ( Meich, Niedzwichi and Smith, 1979 )* Thus it is possible 
for exogenous cAMP analogues to increase the levels of cGMP. This 
would be expected to be important in NA induced contractions, where 
further stimulation is not possible, but where the contraction is 
dependent to a large degree on the ratio of the two nucleotides. 
However, it was not possible to measure the changes in cyclic 
nucleotide levels actually produced in these experiments, so the ■
Fig D4 Exogenous 8-bromo cGMP
The effect of adding 8-bromo cGMP ( 5 x 10"% ) to a contraction induced by KCl ( 80mM ), or NA 
( 2.5 X 10 M ). The agonist was added at "X”, 8-bromo cGMP at "G". The dose was repeated at the second "G", giving a bath concentration of 10"%. The bath was washed out at the dot.
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Fig D5 Exogenous Di-Mtyryl cAMP
The^ - effect of adding Dl-butyiyl cAMP (5 x 10 M ) to a contraction induced by KCl ( 80mM ) or M  ( 2.5 X 10 ). The agonist ims added at"X", Di-butyryl cAMP at "A”, The bath was washed out at the dot.
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results may be open to other interpretations.
6.0 Conclusion.
The data presented in this section supports the veiw that the three 
agonists use different methods of activation, in that KCl 
contractions depend to a large extent upon calcium influx, while NA 
and ACh contractions depend upon this much less. The 
electrophysiological results support the idea that membrane
potential changes per se are not important in the regulation of 
contraction.
In order to explain the different effects of the agonists one 
must postulate the existence of some second messenger process which 
can regulate the contractility of the muscle in a way which is
largely independent of the membrane potential changes. The changes 
in the cyclic nucleotides produced by the agonists suggest that 
this regulation of contraction may be related to the ratio of
cAMP/cGMP in the cells, since a good correllation is obtained
between this and tension.
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SECTION 2; ANTAGONISTS; V and NP.
1.0 Effect of Verapamil; Introduction.
Verapamil was first investigated by Eleckenstein and co-workers 
( Eleckenstein, Kammermeier, Poring and Ereund 1967 ) who showed 
that, in cardiac muscle, it specifically inhibited calcium influx, 
without affecting the resting membrane potential. Subsequently a 
similar effect, ( inhibition of calcium induced contraction in 
depolarised muscle ), was demonstrated in rabbit main pulmonary 
artery ( Haeusler 1972 ). Similar calcium antagonistic effects
have been reported in many other smooth muscle preparations,
( Gruen, Eleckenstein and Tritthart 1971, Eleckenstein, Gruen, 
Tritthart and %ron 1971 )» In the li^t of these results it has 
been postulated that verapamil acts by preventing trans-membrane 
fluxes of calcium. Differential effects of verapamil on the 
contractions induced by different agonists have been observed in 
various smoothinuscle preparations.
The inhibition of KCl induced contractions and NA induced
contractions has been investi^ted in a number of preparations. In 
all instances the KCl induced contractions are inhibited to a 
greater degree, althou^ the effect on the NA induced contractions 
tends to be more variable ( Peiper et al 1971, Golenhofen and 
Hermstein 1975, Golenhofen, Hermstein and lammel 1973, Hausler 
1972, Bilek, Laven, Peiper and Regnat 1974 )• These results are to 
some extent dependent on the concentration used, but are
nevertheless consistent with the idea that verapamil blocks
;
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transmembrane flux of calcium, and so will inhibit those 
contractions which are dependent upon an influx of extracellular 
calcium. Evidence that Verapamil acts in the rat anococcygeus as a 
calcium antagonist can be seen in the calcium dose response curves.
1.1 Calcium Dose Response Curves; (Fi^ R3-1 to R3-4)
It can be seen from Eig R3-3 that Verapamil ( V ) strongly 
inhibits KCl induced contractions. Since the curve for KCl does 
not reach a maximum, it is impossible to determine the effect of V 
on the maximum. However, it is apparent that V causes a shift of 
the curve to the ri^t, while the slope remains unchanged. This is 
indicative, as explained earlier, of a change in the membrane 
permeability. This result is consistent with the ^nerally 
accepted mode of action of V, which is to block trans- membrane 
fluxes of calcium. M  induced contractions are not significantly 
affected by V ( Pig R3-1 ) since they do not depend primarily upon 
calcium influx. The sli^t effect of V, to produce a small shift 
of the curve to the ri^t, may indicate a small, verapamil- 
sensitive component of the contraction ( possibly due to a small 
initial influx of calcium through verapamil sensitive channels, 
rather than ROCs )., This effect is not important in normal 
conditions, however.
ACh induced contractions are inhibited by V. Pig R3-4 shows 
that up to calcium concentrations of 2x 10~%, V causes a shift 
in the calcium dose response curve to the ri^t. This indicates, 
as for KOI contractions, that V has caused a reduction in the
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membrane permeability to calcium, and that this is important for 
the ACh induced contractions. Above 2 x however, V causes
a reduction in the maximum response produced. This would appear to 
indicate that V exerts some sort of non-competitive inhibition of 
the contraction that cannot be overcome by increasing calcium 
concentrations. This additional effect may be linked to the effect 
of hi^ calcium itself, as discussed earlier ( ie effects on the 
receptor binding or membrane stabilising effects ). The 
alternative view is that V can interfere in some way with the 
amplification process postulated in the action of ACh. These 
results indicate that V is acting in the rat anococcygeus primarily 
as a calcium antagonist.
The data from the experiments in which V is added to a pre­
existing contraction induced by 'each of the agonists are also 
consistent with this action of V. The relative lack of effect on 
pre- existing KCl induced contractions ( Eig R4-2 ) can be 
explained since the initial calcium influx ( and therefore rise in 
cytoplasmic calcium concentration ) has already ocurred when V is 
added. The slight inhibition of NA or ACh induced contractions may 
OGurr if there is a sll^t verapamil sensitive component involved 
in these. When V is added the calcium influx will be sli^tly 
reduced. • Calcium sequestration ( or extrusion ) will then tend to 
lower cytoplasmic sequestration, which will lead to a slow 
relaxation.
These results and the differential Inhibition of contractions 
induced by the three agonists is consistent \d.th the veiw that V
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can block influx of calcium and that KCl induced contractions 
depend to a large extent upon this, #iile NA and ACh induced 
contractions depend upon it only to a small extent.
In most smooth muscles the blockage of the influx of calcium 
by V takes the form of a suppression of action potentials, or a 
reduction in their frequency ( Golenhof en and Lammel 1972, Reiner 
and Marshall 1975, Riemer, Dorfler Mayer and Ulbrecht 1974 )• The 
anococcygeus muscle, however, does not generate action potentials 
in normal circumstances ( Creed, Gillespie and Muir, 1975 ), rather 
it produces a slow, graded depolarisation in response to 
stimulation. Althou^ permeability changes to more than one ion 
are probably involved in this response, ( Creed 1972 ), it seems
likely that this depolarisation is at least partially due to an
increase in calcium permeability, resulting in an influx of calcium 
and subsequent muscle activation, this calcium influx being 
particularly important in the case of KCl activation. However, 
more than one calcium channel may be responsible for this calcium 
influx, with different properties ( ie voltage dependent channels, 
which are verapamil sensitive, and receptor operated channels, 
which are not. )
The effect of verapamil on the membrane potential changes
induced by the agonists may clarify the mechanism of the
differential inhibition produced by V on the contractions induced 
by them.
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1.2 Electrophysiology;
Verapamil ( 5 x 10”'^ M ) \ms found to produce a sli^t 
depolarisation in control cells, from -55*2mV to -51.8mV. ( P > 
0.05 ). Although this effect is small, and not hi^ly significant, 
it is the opposite of the result expected, if calcium permeability 
contributes to the resting membrane potential. The , expected 
effect, if V produces a reduction in calcium permeability, would be 
a sli^t hyperpolarisation. However, there is evidence that in 
other smooth muscles calcium plays little part in the determination 
of the resting membrane potential, this being largely due to 
permeability to the other ions ( Siegel et al 1976, Kuriyama 
1963 )• It may be that, in this instance, V is competing for the 
calcium- binding sites which are thou^t to be responsible for 
membrane stabilisation, hence causing a small, generalised increase 
in membrane permeability to other ions ( eg. sodium ). This 
generalised effect, of V on the membrane may account for the 
sli^tly reduced depolarisation produced by NA. The lack of a 
specific effect on the depolarisation produced by NA correllates 
well with the fact that this concentration of V does not 
significantly inhibit NA induced contractions.
However, a more specific action is seen in the case of ACh. 
Here the depolarisation produced by ACh is significantly reduced. 
( see Table R5 ) • This would appear to be an effect specific to 
ACh activation, rather than a generalised effect on the membrane. 
This effect correllates well with the mechanical effects of V, 
since this concentration of V produces about 40^ inhibition of ACh
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induced contractions. It may be that the ROCs opened by ACh have a 
verapamil- sensitive component, so that V can sli^tly reduce the 
depolarisation produced by them. The alternative is that V may 
interfere in some way with the mechanism which couples receptor 
activation with opening of the ROCs. It has been shown that there 
is a measurable delay, or latency, in the response to activation of 
muscarinic ( Hill-Smith and Purves 1978 ) and adrenergic ( Purves 
1978 ) receptors, which may be due to this coupling process. If 
this coupling process is different for NA and ACh, ( as seems 
likely ), then it may be possible that V affects one 
preferentially. This may be due to V interfering in some way with 
calcium bound to the membrane in the region of the receptors. This 
finding may explain why V can reduce the maximum contraction 
produced by ACh in the calcium dose response curves, and may be the 
effect postulated earlier in addition to the calcium antagonistic 
effect.
The effect of V on KCl depolarisation ( ie. no significant 
effect ), was unexpected. It was expected that V would reduce the 
depolarisation produced, by preventing the calcium permeability 
change induced by KCl. However, as stated previously, KCl 
depolarises the membrane by changing the electro- chemical gradient 
for K^, ( and hence the equilibrium potential. ) Depolarisation
by this means would thus still be possible in the face of little or 
no change in the permeability to other ions. Also, the fact that 
this depolarisation itself produces changes in the permeability to 
other ions, by opening voltage dependent channels, complicates the 
situation. If the contribution of calcium permeability changes is
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small compared to these other effects, it seems possible that a 
reduction in calcium permeability would have little effect. In 
fact, when the further complications of ionic pumps in the membrane 
are considered, the result is not surprising.
It is notable that the primary and secondary phases of the KCl 
contractions are almost identical in their sensitvity to V, ( and 
very similar with regard to NP ). This is strong evidence that 
these two phases are not fundamentally diferent in this muscle, 
( ie. they are not due to different activation processes, like the 
P and T systems described in other preparations. ) This supports 
the idea proposed in section 1, that the bi- phasic contraction 
produced by KCl is due to the re- equilibration of calcium within 
the cell.
The results of these experiments indicate that in the rat 
anococcygeus muscle KCl contractions are primarily due to an influx 
of calcium, #iereas NA and ACh induced contractions do not rely to 
such a great extent upon calcium influx, ( since V inhibits KCl 
contractions well, but only poorly inhibits NA and ACh 
contractions. ) It must be born in mind in the interpretation of 
these results, however, that it is possible that NA and ACh produce 
an influx of calcium through channels that are not sensitive to V. 
Such receptor operated channels ( ROCs ) have been proposed to 
exist in many preparations and to have different properties to the 
channels opened by KCl depolarisation, ( voltage dependent 
channels, VDC ). If the number of ROCs is much greater than the 
number of VDCs, this could go some way to explaining the greater
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maximum contraction produced by NA and ACh, as compared to KCl.
It should be noted that V causes the greatest inhibition of 
KCl induced contractions, ( compared with the other agonists ), but 
that it produces no appriecable change in the membrane potential. 
This is further evidence that the membrane potential per se is not 
fundamental in the regulation of contraction.
1.3 NA and ACh; Effects of low calcium;
The efects of N? and V on the contractions induced by NA and
ACh in low calcium solution were investigated, Althou^ the 
concept of P and T system activation does not seem applicable to 
explain the differences in activation produced by the three 
agonists in this muscle, ( see earlier ), it was felt that perhaps 
the different phases of the bi-phasic contractions produced in low 
calcium for NA and ACh would exibit some of the properties of P and 
T systems, ( ie. selective inhibition by NP and V ). As can be 
seen from the results ( Pigs R2-9 to R2-12 ), the different phases 
did display different properties.
The primary phase of the contraction induced by NA in low
calcium is largely unaffected by V, as is the contraction in normal 
calcium. Since V has little effect it is reasonable to suppose
that this primary contraction does not, therefore, depend upon 
influx of extracellular calcium. It seems likely that this 
contraction is produced by the release of intracellular stores of 
calcium by NA. A possible candidate for such a store is the
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calcium associated with the cell menmhrane itself, or possibly 
calcium bound to the receptors themselves ( Bolton 1979 ) • If the 
small amount of calcium so released into the cytoplasm is then 
subsequently sequestered by calcium binding within the cell, 
possibly by mitochondria, sarcoplasmic reticulum or parallel 
structures, etc., then the rise in free calcium levels will be 
transient, producing the observed transient contraction. A general 
model of this type of internal calcium cycling has been proposed by 
Bianchi ( 1969 )• Presumably this primary contraction is not 
sensitve to NP for the same reasons that the contraction in normal 
calcium is not. ( see earlier ). If the small primary contraction 
produced by ACh in low calcium is due to the same sort of mechanism 
as that produced ly NA, it should be relatively insensitive to V. 
This is 'vdiat is found ( Pig R2-11 ).
The later, secondary contraction induced by NA in low calcium 
is inhibited to a large extent by hi^ concentrations of V ( above 
7 x 1 0~'^ M ). This inhibitory effect of V indicates that the 
contraction under these conditions is dependent upon influx of 
extracellular calcium, whereas the contraction in normal calcium is 
not. However, it is reasonable to suppose that the inhibitory 
effect of V will be greater in low calcium since it has been shown 
that V and low calcium produce similar results ( Golenhof en and 
Lammel 1972 ), and also that the effect of V can be overcome by 
hi^ calcium ( Perrari 1970 ). It may be that the contraction 
induced by NA in normal calcium does have a Verapamil- sensitive 
component, but that inhibition of this only becomes important at 
low calcium concentrations.
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The secondary phase of contraction induced by ACh in low 
calcium shows very similar properties to the contractions in normal 
calcium. One of the effects of reducing the calcium concentration 
is to increase the effectiveness of V, which is consistent with the 
mechanism of action of V as a calcium antagonist.
1.4 Summary
The data presented in this section supports the view that V 
acts as a calcium antagonist in the rat anococcygeus. The 
inhibitory effect of V on the contractions induced by the three 
agonists support lead to the following conclusions.
1 ) KCl induced contractions depend largely upon an 
■ influx of extracellular calcium. V causes inhibition by preventing 
this influx.
2) The two phases of the contractions induced by KCl
are not due to different activation mechanisms, but are due to 
calcium re- equilibration within the cell.
3) NA induced contractions are not dependent upon calcium 
influx in normal circumstances.
4) ACh induced contractions appear to have a Verapamil- 
sensitive component. Electrophysiological evidence suggests that 
this may be an effect of V on receptor coupling or on the ACh 
operated channels.
5) The initial event in NA and ACh induced contractions
is either a small calcium influx which is not verapamil sensitive, 
or (more likely) a small release of intracellular stores of
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calcium, possibly from sites associated with the receptors 
themselves.
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2.0 Effect of NP; Introduction;
Nitroprusside is generally accepted as producing a pronounced rise 
in cGMP levels in a variety of smooth muscle preparations, while 
leaving cAMP levels substantially unchanged ( Schultz et al 1977, 
Katsuki and Murad 1977 ). This rise in cGMP levels usually occurs 
along with a relaxant effect, for example in muscles depolarised by 
high solutions. The suggestion that the relaxant effects of 
NP are mediated via a rise in cGMP has recently been challenged by 
other workers however ( Diamond and Janis 1978 ). They have found 
little correllation between the levels of cGMP and the relaxant 
effects produced by NP in the rat vas deferens.
It has also been suggested that NP exerts its relaxant effects 
via some effect on the cell membrane, so that the changes in cGMP 
levels which occur later in the activation process are incidental 
to contraction or relaxation and not causally related to it. In 
support of this view, NP has been reported to hyperpolarise 
arterial smooth muscle ( Haeusler 1975 ) and rabbit portal vein 
( Ito, Suzuki and Kuriyama, 1978 ), although it is disputed whether 
NP reduces the calcium influx produced by hi^ K"^  solutions ( no 
effect or increase- Zoster, Henein and Wolchinski 1977, reduction- 
Kreye, Baron, Luth and Schmidt- Gayk 1975 ). NP was also found to 
produce slight hyperpolarisation of the rat anococcygeus in this 
study. Althou^ the mechanism of action of NP remains a matter of 
some dispute, it is undoubtably true that its mode of action is 
very different from that of Verapamil. If there are differences in 
the activation pathways of the different agonists, it is reasonable
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to suppose that V and NP will affect them in different ways. The 
differential effects of V and NP have been invest^ted in a number 
of preparations. NP has been shown to inhibit a component of 
contraction in some preparations that is resistant to nifedipine 
( an analogue of Verapamil ) ( Golenhofen, Wagner and Weston
1977 ).
HP and V were used ly Golenhofen (1973,1976) to support the
hypothesis that there are two different activation mechanisms in 
smooth muscle that differ in their responses to these antagonists. 
These two systems are designated P ( Phasic ), which is inhibited 
selectivly by V, and T ( Tonic ), which is inhibited by NP. It 
should be noted, however, that NP is not a T system antagonist in 
all tissues, and also that Golenhofen does not acknowledge the 
possible involvement of cGMP in the action of NP.
On the basis of this finding it would be supposed that KCl 
contractions in the rat anococygeus would be insensitive to NP but 
that NA contractions would be inhibited (ie. KCl acts primarily 
via a P type system, whereas NA acts via a T type system). ACh 
contractions would be expected to be intermediate in their 
sensitvity to NPj as for V. As can be seen from figs R2-2 and 
R2-3j KCl contractions are indeed largely insensitive to NP ( both 
primary and secondary phases ). However, NA contractions are also 
unaffected by NP (up to 10""% ). The inhibition of ACh 
contractions is as predicted, being about 40^.
The results indicate that the concept of two activation
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systems ■ which are stimulated to different degrees by the agonists,
( such as the P and T systems described by Golenhofen in other 
muscles ), is not applicable to the action of the three agonists on 
the rat anococcygeus muscle. The fact that ACh contractions are 
inhibited by NP, whereas NA contractions are not, must indicate 
that ACh and NA use different activation pathways. It appears, 
therefore, that a sli^tly different mode of activation must be 
proposed for each of the three agonist in the rat anococcygeus 
muscle. It must be emphasised here that the concept of P and T 
systems was evolved largely from results with spontaneously active 
smooth muscles, which usually produce bursts of action potentials 
( eg stomach fundus ). It may be that the response to different 
agonists in the anococcygeus muscle, which does not produce action 
potentials, is more subtle and the different agonists use sli^tly 
different activation pathways. These activation pathways may 
involve changes in second messenger substances within the cell, 
( eg cyclic nucleotides ).
The evidence presented in the previous section, dealing with 
the effects of V, supports the idea that membrane potential per se 
is not important in the regulation of contraction, or in the 
inhibition produced by V. The membrane effects of NP were 
investigated in order to asses if these were important in the 
inhibition produced by it.
2.1 Electrophysiology
NP has been reported as producing hyperpolarisation of smooth
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muscle cells ( Ito et al 1978 ). In this study it was found that 
NP ( 2 X 10” M ) also produced a small hyperpolarisation of the 
cells of the rat anococcygeus ( of about 2.8mV ). This effect was 
not significant when compared to the control value, however. NP 
had pronounced effects on the depolarisation produced by NA and 
ACh. In the presence of NP ( 2 x 10”%  ) both NA and ACh 
produced less depolarisation than in the control group. This 
effect was significant in both cases. It is difficult to reconcile 
these results with the most generally accepted mode of action of 
NP, namely that it increases cGMP levels in the cells which then 
acts in some way to produce relaxation, althou^ it has been 
suggested that cGMP could exert a negative feedback effect which 
could reduce calcium influx ( Schultz et al 1977 ). As stated 
previously, calcium permeability changes are unlikely to be of 
importance in the action of adrenergic or muscarinic receptors. 
The primary effect of these is thought to be an increase in sodium 
permeability. However, it is possible that cGMP could affect all 
of the permeability changes produced by ROCs ( by interfering with 
the ROCs themselves ). In this way NP could indirectly ( via 
cGMP ) reduce the depolarisation produced by NA or ACh.
KCl is thou^t to act primarily by opening voltage dependent 
channels which increase the membrane permeability to calcium and 
other ions such as sodium. Since NP was found not to reduce the 
depolarisation produced by KCl, one is forced to conclude that, if 
NP is acting via cGMP to reduce the permeability changes, the 
effect is confined to channels opened ly NA or ACh receptors, 
( ROCs ), ie. that only ROCs are sensitive to intracellular
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changes in cGMP. The other possibility is that NP is acting 
directly on the coupling of receptor activation with the opening of 
these ROCs. This may be possible since organic nitrate 
vasodilators have been reported to interact with sulphydryl groups, 
either on the cell membrane ( Smith and Krusyma, 1976, Winbury, 
Howe and Hefner 1969 ), or associated with specific receptor sites 
( Needleman and Johnson, 1973 ). However, later papers ( Ito, 
Kityamura and Kuriyama, 1980 ) have suggested that nitroglycerine 
( and presumably related compounds ) act on the final, calcium 
releasing stage of activation, rather than at the membrane. This 
was suggested on the basis of its non- selective action. The 
evidence of this study would suggest that it is not likely that NP 
acts in this way in the rat anococcygeus, since NP has different 
effects on the activation produced by the three agonists.
It would seem that NP acts in the rat anococcygeus either by 
affecting the coupling of receptor activation to the opening of 
ROCs, by interfering in some way with the ROCs, to reduce the 
permeability change produced, or by acting on some later stage in 
the different activation processes used by each agonist. The 
differential effect of NP on the contractions produced by ACh and 
NA suggests that, at least part of its effect is to interfere with 
the different activation processes used by NA and ACh, subsequent 
to the initial membrane events. However, since it is able to 
reduce the depolarisation produced by both NA and ACh, some of its 
effects must be on the coupling of receptor activation to membrane 
depolarisation. This effect is not due to a generalised effect on 
the membrane, since KCl depolarisation is not affected.
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It appears, therefore, that NP acts in more than one way to 
produce inhibition in this preparation. One of these is by 
interfering with the depolarisation of the membrane produced by 
receptor activation. The other is by interfering with the later 
stages in the activation process, either directly or indirectly 
(via cGMP changes). However, these results are those obtained at 
normal calcium concentrations. The pattern of inhibition produced 
by NP is influenced by the calcium concentration, as can be seen in 
the calcium dose response curves.
2.2 Calcium Dose Response Curves (Ei^ 3-1 to 3-4)
Althou^ NP produces no significant inhibition of NA or KCl 
induced contraction at normal calcium concentrations, a significant 
inhibition is produced in both cases at lower calcium 
concentrations, ( around 5 x 10”%  ), ie. NP is a more effective 
antagonist at low calcium concentrations. This point is important 
in the consideration of the mode of action of NP. This effect 
( significant inhibition at low calcium concentrations ) is also 
shown for ACh induced contractions, although in this case NP shows 
an additional effect, in that the inhibition is maintained at 
hi^er calcium concentrations leading to the 40^ inhibition seen in 
normal solutions.
This increased efectiveness of NP at low calcium 
concentrations supports the idea that NP acts by increasing cGMP 
levels in the tissue which may then act to reduce calcium influx, 
or may produce other inhibitory effects.
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Interesting results in this context were obtained from two 
experiments designed to investigate the calcium dependency of the 
changes induced in cyclic nucleotide levels by the agonists. The 
conditions of the experiments were the same as for those which 
investigated the changes in cyclic nucleotide levels due to the 
action of NA or KCl, except that calcium was omitted from the Krebs 
solution. The results of these experiments were;
PROTEIN cAMP cGMP RATIO
mg. pnol/mg.
NA/Low Ca 10.5 1.35 0.54 2.3
KCl/liOw Ca 9.75 0.81 0.30 2.7
CONTROL 8.25 0.90 0.37 2.6
It can be seen that the fall in cGMP normally produced by NA or KCl 
is not produced in low calcium solution. Note that NA still 
produces a sli^t rise in cAMP, thou^t to be due to a small p 
effect, so this effect is not calcium dependent. The sli^t rise 
in cGMP produced by NA in low calcium conditions may be linked in 
some way to this rise in cAMP. ( since the two can affect each 
other, as stated previously, eg. cAMP may compete as a substrate 
for phosphodiesterase. ). Note that the ratio produced by NA and 
KCl in low calcium solutions were very similar to the values for 
control muscles.
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Similar results showing the calcium dependency of changes in
cGMP levels in a number of preparations have been reported
( Diamond and Janis 1980, Nilsson and Andersson 1977, Schultz et al 
1973 ) • Note that the changes produced by NP were not calcium 
dependent in many cases. Unfortunatly, it was not possible to 
investigate this in this study.
The results of these experiments would explain the mechanical 
effects of NP very well. Since the cyclic nucleotide changes 
induced by the agonists are calcium dependent, the amplification 
stage of the activation process due to them will be less effective 
in low calcium conditions. Since the changes in cyclic nucleotide 
levels produced by NP, however, are not dependent upon 
extracellular calcium, the effect of NP on cyclic nucleotide 
levels, ( and therefore presumably on tension produced also ), will 
become more important at low calcium concentrations.
Similar theories can be advanced to explain the data for ACh
induced contractions. The main difference in this case is that the 
activation process used by ACh in normal calcium is more sensitive 
to NP ( and to some extent V ), so that one is forced to conclude 
that NP has some additional effect on ACh induced contractions 
which is important at normal calcium concentrations ( as well as 
the effect at low calcium concentrations seen also with NA and KCl 
induced contractions ). Just what this effect could be is 
difficult to see. Since the inhibition of the membrane 
depolarisation produced by NP is vepy similar for NA and ACh, it 
would seem that the effect is not due to some specific efect of NP 
on the ACh ROCs. It may be that NP can exert some specific effect
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on ACh induced contractions "by interaction with some later stage in 
the activation process. A similar type of effect has heen proposed 
by Kreye et al (1975). This effect may be unrelated to the effects 
of NP on cGMP levels, althou^ it is possible that the cyclic 
nucleotide changes induced by M  and ACh take place in different 
cellular compartments, with different sensitivities to ÎTP. This 
concept of compartmentalisation may also be necessary to expain the 
lack of cor reflation found between the cyclic nucleotide changes 
and the relaxant effects induced by -EP in the next section.
3.0 Cyclic Nucleotides; Effect of NP.
The data presented in the previous sections supports the 
hypothesis that cyclic nucleotide levels are important in the 
regulation of contractility in the rat anococcygeus. However, it 
has been reported in many instances that it is possible to change 
the level of one or other of the cyclic nucleotides without 
concommitant changes in contractility, and vice-versa ( Diamond and 
Holmes, 19757 Schultz, Schultz and Hardman, 1975, Andersson 1975 )• 
One of the agents which can produce this dissociation of the 
changes in cyclic nucleotide levels and contractility is sodium 
nitroprusside ( HP ) ( Diamond and Janis, 1978 ),
The experiments in this study showed that HP can produce a 
large rise in cG^ lP levels in the rat anococcygeus, as has been 
found in many other preparations. If this change in CGMP is 
responsible for the relaxant effect of HP, then when the change in 
the ratio of cAMP/cGMP produced by HP is plotted against the
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tension change also produced, this point should lie on or near to
the straight line on Pig D3« This is assuming that the cyclic
nucleotide ratio is important in determining the tension produced
by the agonists. HP ( 2 x 10"% ) actually produces a rise in
cGMP to about 0.76 pmol/mg., with little change in cAMP levels.
The ratio cAMP/cGMP so produced is 0.9 ( see cyclic nucleotide
results, table R3 ). This ratio is produced when the muscles are
treated with M  after HP. HA alone produces a ratio of 8.2 This is
a dramatic change in cyclic nucleotide levels. However, the same
concentratio of HP produces only about 10^ relaxation of HA induced
contractions, ie. the tension falls from about 250Hm to around
230 Hm"^. This point ( ie a tension of 230Hm"^ and a ratio of
0.9 ) is plotted on Pig D3. It can be seen that it lies well off
the line through the points produced by the agonists alone. A
similar experiment was performed using muscles pre- treated with HP
and then contracted with KOI. Unfortunatly it was only possible to
assay one pool of 8 muscles. The ratio cAMP/cGMP was 1 .56 in this
case. The tension in the mechanical experiments - was reduced to
—2around 70 HnT by this same concentration of HP. This point is 
also plotted on Pig D3 and it can be seen that it also lies well- 
off the line produced by the agonists.
The results of these experiments with HP support the view of 
Diamond and Janis ( 1978 ), that increases in the levels of cGMP 
may not mediate the relaxant effects of HP. However, one is 
reluctant to abandon altogether the idea that the cyclic nucleotide 
ratio is important in the regulation of contraction. The evidence 
presented in section 1, ( the good correllation between the ratio
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and the tension produced by the three agonists.), appears to be 
very strong evidence in favour of this theory. The theory also 
explains the data from the calcium dose response curves very well 
( that HP is more effective at low calcium concentrations ), since 
the changes in the cyclic nucleotides induced by the agonists were 
found to be calcium dependent.
The alternative to abandoning the theory altogether is to 
suppose that some canpartmentalisation occurs within the cell. One 
can suppose that cyclic nucleotide changes occur in many different 
cellular compartments, only one of which is important in the 
regulation of contraction. This important compartment is presumed 
to be very small in comparison to the others. It may be that under 
most circumstances the changes in the cyclic nucleotide ratio in 
all of the compartments are similar, so that a good correllation 
exists between the gross changes in cyclic nucleotide ratio and 
tension. HP may act differently in some compartments compared to 
others, however. In this case the gross changes in cyclic 
nucleotide ratio recorded may not be a true representation of that 
occurring in the small compartment which is important in the 
regulation of contraction. This would lead to the result obtained 
with HP, that the ratio of the nucleotides produced does not 
correllate well with the changes in tension. Such a 
compartmentalisation has been proposed in other preparations by 
Andersson, Hilsson, Vikberg, Johansson, Mohme-Lundholme and 
Lundholm (1975) and Poison, Krzanowski, Fitzpatrick and Sztenivanyi 
(1978).
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3.1 Summary
The data presented in this section make it possible to produce 
theories regarding the mode of action of HP, althou^ it is 
difficult to reach definite conclusions.
NP raises cGMP levels. This effect is probably not dependent 
upon extracellular calcium.
The effects of the agonists on cyclic nucleotide levels are 
calcium dependent.
This means that HP is more effective at low calcium concentrations.
This data supports the veiw that the primary action of HP is to 
raise c(MP levels intracellularly, which then produces some 
inhibitory effect, either a reduction in calcium influx, or some 
other effects. ( eg effects on MLGK ). The relative importance of
these effects will depend upon just how much calcium influx is 
necessary for contraction in each case.
In order to explain satisfactorily the lack of correllation between 
cGMP levels and tension, however, a model of cellular 
compartmentalisation must be proposed in which the levels of cyclic 
nucleotides measured do not necessarily reflect those which are 
important in the regulation of contraction.
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In addition to these effects it appears that HP can exert an effect 
specific to ACh activation, which leads to significant inhibition 
of ACh induced contractions even at normal calcium concentrations. 
This effect may be related to the concept of compartmentalisation 
also.
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AHTAGONIST DOSE RESPONSE CURVES; STZ and Theo.
1.0 Introduction
The effects of Stellazine ( STZ ), (Trifluroperazine) and 
Theophylline ( Theo ) on the contractions induced by each of the 
three agonists were investigated. STZ is thou^t to exert its 
effects at the level of MLCK activation by calcium. Smooth muscle 
is thou^t to produce tension when the 20,000 Dalton subunit of 
myosin li^t chains is phosphorylated. This allows the myosin- 
actin interaction which generates tension ( Chacko, Conti and 
Adelstein 1977, Gorecka, Aksoy and Hartshorne 1976 ). %osin li^t 
chains are phosphorylated by a kinase, MLCK, which has as part of 
its stucture a calcium sensitive subunit ( Drabowski, Aromatoril, 
Sherry and Hartshorne 1977, Drabowski, Sherry, Armatqrio and 
Hartshorne 1978 ). This subunit confers calcium sensitivity upon 
MLCK,and hence upon the contractile system as a whole. This 
calcium sensitive protein has also been shown to be involved in the 
activation of numerous other enzymes and is generally refered to as 
calmodulin, ( CALcium sensitive MODULator proteIN ) ( Walsh,
Vallet, Cavadore and Démaillé 1980 ).
STZ has been shown to bind to calmodulin in various enzyme 
systems ( Levin and Weiss 1976,1977 ). It is thougjht that this 
prevents the activation of these enzymes by calcium. It has also 
been shown that STZ can inhibit the calcium activation of smooth 
muscle MLCK and this is thou^t to be responsible for the 
inhibition of tension ( Cassidy et al 1980 ). The basic hypothesis
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for the mode of action of STZ, therefore, is that it prevents the 
calcium sensitive activation of MLCK by calmodulin, thus preventing 
myosin li^t chain phosphorylation and subsequent tension 
development ( see Fig G3 ). However, it must be born in mind that 
many diverse enzyme systems have been shown to depend on activation 
by calmodulin, eg. phosphodiesterase ( Cheung 1979 ), adenyl 
cyclase ( Brostrom, Huang, Breckenridge and Wolff 1975 ), 
phosphoiylase kinase ( Cohen 1979 ) and so STZ may have an 
influence on many diverse processes within the cell.
Theophylline ( Theo ) has been shown to inhibit 
phosphodiesterase in a number of tissues ( Newman, Colella, 
Spainhow, Bramn, Zobko-Potapovich and Wardell 1978, Poison, 
Krzanowski, Adersson, Fitzpatrick, Huang and Szentivanyi 1979 )• 
There is generally a good correllation between the inhibition of 
phosphodiesterase catalysed cAMP hydolysis and the inhibition of 
tension in many tissues and this has been proposed as the mode of 
action of Theo. However, in many instances the concentration of 
Theo necessary for phosphodiesterase inhibition was many times 
greater than that necessary for inhibition of tension. Also, 
phosphodiesterase occurs in many forms, ( ie. a hi^ and a low Km 
form ), and many of these enzyme studies have been done on the hi^ 
Km ( low affinity ) form, using hi^ substrate concentrations. It 
has been shown that, at low substrate concentrations, 
phosphodiesterase from brain hydrolyses cCMP faster than cAMP, 
( Brostrom and Wolff 1976 ). Also, the Km is lower for cGMP. 
Phosphodiesterase from glial tumour cells has been shown to be more 
sensitive to calcium when cGMP is the substrate, rather than cAMP.
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( Brostrom and Wolff 1974 ).
These results cast doubt upon the hypothesis that Theo 
produces its relaxant effects by inhibition of phosphodiesterase. 
It seems possible that Theo could alter levels of cAMP and cGMP in 
ways which could not be predicted from the in vitro data. Very few 
experiments have been done to investigate the changes in cyclic 
nucleotide levels actually produced in vivo by Theo.
An alternative mode of action for Theo has been proposed by Meich, 
Hiedzwicki and Smith (1979). They have shown that there is a cAMP 
binding protein in tracheal smooth muscle. The binding of cAMP to 
this protein is increased by Theo ( leading to a reduction in cAMP 
levels ) at concentrations much lower than those needed for 
phosphodiesterase inhibition. cGî^îP can reduce the binding of cAMP, 
by substrate competition, so accounting for the interrelationship 
often seen between the two nucleotides.
2.0 The Rat Anococcygeus.
The results obtained in this study showed that the 
contractions produced by all three agonists were inhibited by STZ 
and Theo ( Figs R2-5 to R2-8 ). In all cases STZ was the most 
potent antagonist. This difference in potency is markedly less for 
ACh induced contractions, however. This can be seen more clearly 
when the results are replotted as ^ of control tension against 
concentration of STZ or Theo ( Figs D6A/B ). When the data is 
plotted in this way it is noticeable that HA induced contractions
Pig D6 A Effect of STZ
The results of the antagonist dose response curve for STZ for each agonist plotted as fo control response for each agonist.
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are less sensitive than ACh or KCl induced contractions to hoth STZ 
and Theo. Presumably this is due to the more powerfull ( or subtly 
different ) activation processes induced by M .  In the case of 
Theo, it seems reasonable to suppose that the changes induced by 
Theo will be less effective against the background of the large 
changes induced by M  itself ( see section 1 ).
The inhibition of MLGK activation produced by STZ cannot be 
overcome by increasing the calcium concentration ( Levin and Weiss 
1976 ). This indicates that, since the contractions induced by ACh 
or M  are less inhibited by STZ, these agonists are producing a 
greater contraction than KCl by some other means than by producing 
a greater rise in intracellular free calcium concentration, ie.- 
there is some amplification process involved in the activation 
pathway. All the evidence to date supports the view that M  and 
ACh produce less rise in Intracellular calcium concentration than 
does KCl.
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GENERAL CONCLUSION
The overall scheme for the activation of the Rat anococcygeus 
hy  ^the three agonists "vdiich fits the data most consistently is 
shown in Pigs G1 and G2.
Pig G1 shows the proposed scheme for KCl activation. Calcium 
enters the cells via voltage dependent channels, which are opened 
when the hi^ extracellular concentration of KCl depolarises the 
membrane. This influx of calcium is inhibited stron^y by 
Verapamil. The rise in intracellular calcium so produced has two 
main effects. 1) It activates the contractile proteins ( via 
MLGK ) and 2) it causes a fall in C.GMP levels ( probably by the 
calcium- dependent activation of a phosphodiesterase ).
The free intracellular calcium is also exchanged with 
intracellular stores, \diich produces the charateristic bi-phasic 
contraction seen with KCl activation. cGMP may act to increase the 
binding of calcium to the stores and/or to reduce the influx of 
calcium throu^ the membrane. These effects can account for the 
observed effects of NP, since this acts to increase cGMP levels. 
How NP causes a rise in cGMP is not known.
Pig G2 shows the proposed scheme for NA and ACh activation. 
The activation processes for these two agonists are very similar in 
principal.
Activation of the muscarinic or alpha adrenergic receptor
Pig G1 General scheme for activation hy KCl
KCl
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Initially causes the release of a small amount of intracellularly 
bound calcium, possibly asociated with the receptor itself. This 
small amount of calcium can cause a small contracion under certain 
circumstances ( eg in low calcium solutions ). Receptor activation 
also generates some hypothetical signal which acts in conjunction 
with calcium to cause a fall in cGMP levels. This effect may be 
due to a calcium- dependent phosphodiesterase associated with the 
receptor.
Receptor activation also opens ROCs associated with the 
receptors, so allowing an influx of calcium. This influx raises 
intracellular free calcium levels, an effect which may be enhanced 
by the calcium induced release of intracellular calcium stores, 
which then produces the following effects. 1 ) It acts with the
hypothetical signal from the receptor to lower cGMP levels. 2) It 
causes the activation of the contractile proteins ( via MLGK ). 
This activation is enhanced greatly by the effects on c(MP levels 
( possibly via an MLCK phosphorylase ). This leads to the 
possiblity that M  and ACh can produce a greater rise in tension, 
althou^ the rise in free calcium in the cell is smaller, when 
compared to KCl activation.
RP acts by causing a rise in cGMP levels. This in turn; 1) 
reduces the "amplification” of the calcium signal due to the fall 
in cGMP normally seen upon activation, and 2) increases calcium 
uptake into intracellular stores and/or reduces calcium influx ( as 
for KCl activation ). In the case of ACh RP may also affect the 
coupling of receptor activation to the "amplification" stages of
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the activation process ( possibly by affecting the hypothetical 
signal which lowers cGMP levels. )
Verapamil also has this type of effect on ACh activation and 
probably also reduces the influx of calcium throu^ ROCs sli^tly. 
The effects of V on NA activation are much less pronounced. These 
latter effects of NP and V are shown on the figures as NP? and V?.
STZ is proposed to act in the same way for all three agonists. 
The proposed scheme is shown in Eig G^. STZ prevents the calcium- 
dependent activation of MLCK by calmodulin, hence causing an
ihibition of tension generation. It may also interfere with the 
calcium- dependent activation of many other enzymes. The fact that 
NA ( and to a lesser extent ACh ) activation is less dependent upon 
a rise in intracellular calcium ( due to the "amplification"
processes occurring ) means that contractions induced by these 
agonists are less inhibited by STZ,
The effects of Theo are probably due to inhibition of 
phosphodiesterase, which causes a rise in cGMP levels. This in 
turn will produce inhibition of tension as seen in the way outlined 
above. However, Theo undoubtably affects cyclic nucleotides in a 
more comlicated way than, say, NP, ( possibly by effects on a cAMP 
binding protein ), so that the effects on activation by the
agonists are different to those produced by NP.
The scheme proposed above is a simplified picture of the
activation processes and the effects of the antagonists. In
Eig G5 General scheme for the mode of action of STZ and Theo
Theo STZ
C.AMP
MLCK-©
[ C a ^  ]
( inactive)
MLCK-gg) 
(active )
Myosin+Pi Myosin©
wCONTRACTION
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reality the situation is undoubtably more complex. In particular, 
some form of compartmentalisation of the activation processes must 
be proposed if the scheme is to fit all the data. In addition to 
their effects on contractiliy, cyclic nucleotides can also
influence many diverse processes within the cell. Part of the 
function of the changes in cyclic nucleotide levels produced by 
activation may be, therefore, to syncronise the events necessary 
for contraction upon activation. The effects on contracility
itself may only be a minor part of their role.
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